CAS No.: 950736-05-7
B-Raf IN 1 Catalog No. CSN16988
Synonyms: B-RAF IN 1;B-RAF Inhibitor 1;MDK-36057
B-Raf IN 1 is a highlt potent and selective B-Raf inhibitor with IC50 of 24 nM, equipotent against c-Raf (IC50= 25 nM).
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT03430947 Malignant Melanoma Stage IV ... more >> BRAF V600 Mutation Brain Metastases Collapse << Phase 2 Recruiting August 31, 2021 Germany ... more >> Technische Universität Dresden Recruiting Dresden, Germany, 01307 Contact: Friedegund Meier, MD +49 351 458 ext 2497 friedegund.meier@uniklinikum-dresden.de Contact: Esther Troost, MD +49 351 458 ext 2394 esther.troost@uniklinikum-dresden.de Principal Investigator: Friedegund Meier, MD Principal Investigator: Esther Troost, MD, PhD Ruprecht-Karls-University of Heidelberg, Faculty of Medicine Not yet recruiting Heidelberg, Germany, 69120 Contact: Jessica Hassel, MD Eberhard Karls University of Tübingen, University Medical Center Not yet recruiting Tuebingen, Germany, 72076 Contact: Thomas Eigentler, MD Collapse << NCT01340846 Cancer Phase 1 Completed - United States, Arizona ... more >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, Florida GSK Investigational Site Sarasota, Florida, United States, 34232 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43210 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84112 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 United Kingdom GSK Investigational Site Headington, United Kingdom, OX3 7LJ GSK Investigational Site London, United Kingdom, W1G 6AD Collapse << NCT01909453 Melanoma Phase 3 Active, not recruiting March 31, 2019 - - 更多
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 950736-05-7 | 储存条件 |
|
|
| 分子式 | C29H24F3N5O | 运输 | 蓝冰 | |
| 分子量 | 515.53 | 别名 | B-RAF IN 1;B-RAF Inhibitor 1;MDK-36057 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
|---|
| NCT03430947 | Malignant Melanoma Stage IV ... more >> BRAF V600 Mutation Brain Metastases Collapse << | Phase 2 | Recruiting | August 31, 2021 | Germany ... more >> Technische Universität Dresden Recruiting Dresden, Germany, 01307 Contact: Friedegund Meier, MD +49 351 458 ext 2497 friedegund.meier@uniklinikum-dresden.de Contact: Esther Troost, MD +49 351 458 ext 2394 esther.troost@uniklinikum-dresden.de Principal Investigator: Friedegund Meier, MD Principal Investigator: Esther Troost, MD, PhD Ruprecht-Karls-University of Heidelberg, Faculty of Medicine Not yet recruiting Heidelberg, Germany, 69120 Contact: Jessica Hassel, MD Eberhard Karls University of Tübingen, University Medical Center Not yet recruiting Tuebingen, Germany, 72076 Contact: Thomas Eigentler, MD Collapse << |
| NCT01340846 | Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, Florida GSK Investigational Site Sarasota, Florida, United States, 34232 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43210 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84112 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 United Kingdom GSK Investigational Site Headington, United Kingdom, OX3 7LJ GSK Investigational Site London, United Kingdom, W1G 6AD Collapse << |
| NCT01909453 | Melanoma | Phase 3 | Active, not recruiting | March 31, 2019 | - |
| NCT01603212 | Melanoma | Phase 1 Phase 2 | Completed | - | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT02145910 | Recurrent Melanoma ... more >> Stage IV Melanoma Tumors Metastatic to Brain Collapse << | Phase 1 | Withdrawn(Study was never open... more >>ed to accrual. There is no clinical benefit to patients.) Collapse << | - | - |
| NCT01907802 | BRAF Gene Mutation ... more >> Hepatic Complication Renal Failure Solid Neoplasm Collapse << | Phase 1 | Terminated | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Colorado University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Canada, Ontario University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse << |
| NCT01107418 | Malignant Melanoma | Phase 1 | Completed | - | United States, California ... more >> La Jolla, California, United States, 92093 San Francisco, California, United States, 94115 Stanford, California, United States, 94305 United States, Connecticut New Haven, Connecticut, United States, 06510-3289 United States, Illinois Chicago, Illinois, United States, 60637 Park Ridge, Illinois, United States, 60068 United States, Iowa Sioux City, Iowa, United States, 51101 United States, Nebraska Omaha, Nebraska, United States, 68114 United States, Ohio Columbus, Ohio, United States, 43219 United States, Rhode Island East Providence, Rhode Island, United States, 02915 United States, Virginia Charlottesville, Virginia, United States, 22908 Australia, South Australia Adelaide, South Australia, Australia, 5000 Australia, Victoria Melbourne, Victoria, Australia, 3181 Collapse << |
| NCT02631447 | Metastatic Melanoma | Phase 2 | Recruiting | December 2021 | Austria ... more >> Medical University of Vienna Not yet recruiting Wien, Austria, 1090 Contact: Christoph Hoeller, MD Principal Investigator: Christoph Hoeller, MD France APHM Hopital de la Timone Not yet recruiting Marseille, France, 13005 Contact: Jean Jacques Grob, MD Principal Investigator: Jean Jacques Grob, MD Hôpitaux Universitaires Saint-Louis Not yet recruiting Paris, France, 75010 Contact: Celeste Lebbè, MD Principal Investigator: Celeste Lebbè, MD Institut Gustave Roussy Not yet recruiting Villejuif, France, 94800 Contact: Caroline Robert, MD Principal Investigator: Caroline Robert, MD Germany University of Tuebingen Not yet recruiting Tuebingen, Germany, 72074 Contact: Benjamin Weide, MD Principal Investigator: Benjamin Weide, MD Greece University of Athens Not yet recruiting Athens, Greece, 11527 Contact: Helen Gogas, MD Principal Investigator: Helen Gogas, MD Italy IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T) S.r.l. Recruiting Meldola, Forlì-Cesena, Italy, 47014 Contact: Massimo Guidoboni, MD Principal Investigator: Massimo Guidoboni, MD National Institute of Cancer Recruiting Bari, Italy, 70124 Contact: Michele Guida, MD Principal Investigator: Michele Guida, MD Università degli Studi di Bari Aldo Moro Not yet recruiting Bari, Italy, 70124 Contact: Francesco Silvestris, MD Principal Investigator: Francesco Silvestris, MD Azienda Ospedaliera Papa Giovanni XXIII Recruiting Bergamo, Italy, 24127 Contact: Mario Mandalà, MD Principal Investigator: Mario Mandalà, MD IRCCS San Martino - IST Recruiting Genova, Italy, 16132 Contact: Paola Queirolo Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori Recruiting Milano, Italy, 20133 Contact: Michele Del Vecchio, MD Principal Investigator: Michele Del Vecchio, MD IEO - Istituto Europeo di Oncologia - IRCCS Recruiting Milano, Italy Contact: Pierfrancesco Ferrucci Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" Recruiting Naples, Italy, 80131 Contact: Paolo Ascierto, MD Principal Investigator: Paolo Ascierto, Md Azienda Ospedaliero Universitaria Federico II Not yet recruiting Naples, Italy Contact: Sabino De Placido Istituto Oncologico Veneto Recruiting Padova, Italy, 35128 Contact: Vanna Chiarion-sileni, MD Principal Investigator: Vanna Chiarion-sileni, MD Istituto Nazionale Tumori Regina Elena Recruiting Roma, Italy, 00144 Contact: Virginia Ferraresi, MD Principal Investigator: Virginia Ferraresi, MD Istituto Dermopatico dell'Immacolata - IDI - IRCCS Recruiting Roma, Italy, 00167 Contact: Paolo Marchetti, MD Contact: A Principal Investigator: Paolo Marchetti, Md IRCCS Casa Sollievo della Sofferenza Recruiting San Giovanni Rotondo, Italy Contact: Evaristo Maiello Azienda Ospedaliera Universitaria - Città della Salute e della Scienza di Torino Not yet recruiting Torino, Italy, 10126 Contact: Maria Teresa Fierro, MD Principal Investigator: Maria Teresa Fierro, MD Azienda Ospedaliera Universitaria Integrata di Udine Not yet recruiting Udine, Italy Contact: Alessandro Minisini, MD Spain Hospital Clínic Barcelona Not yet recruiting Barcelona, Spain, 08036 Contact: Ana Arance, MD Principal Investigator: Ana Arance, MD Clinica Universidad de Navarra Not yet recruiting Pamplona, Spain, 31008 Contact: Salvador Algarra, MD Principal Investigator: Salvador Algarra, MD Sweden Karolinska University Hospital Not yet recruiting Stockholm, Sweden, S-171 Contact: Johan Hansson, MD Principal Investigator: Johan Hansson, MD Switzerland Centre Hospitalier Universitaire Vaudois Not yet recruiting Lausanne, Switzerland Contact: Oliver Michielin University Hospital Zurich Not yet recruiting Zurich, Switzerland, CH809 Contact: Reinhard Dummer, MD Principal Investigator: Reinhard Dummer, MD United Kingdom The Royal Marsden NHS Foundation Trust Not yet recruiting London, United Kingdom, SW36J Contact: James Larkin, MD Principal Investigator: James Larkin, Md The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, M204B Contact: Paul Lorigan, MD Principal Investigator: Paul Lorigan, MD Collapse << |
| NCT03714958 | Colorectal Cancer ... more >> Advanced Cancer Metastatic Cancer Collapse << | Phase 1 | Not yet recruiting | November 2020 | - |
| NCT01107418 | - | - | Completed | - | - |
| NCT03721120 | Metastatic Lung Cancer | Not Applicable | Not yet recruiting | July 1, 2021 | - |
| NCT02089724 | - | - | Recruiting | April 2019 | United States, New York ... more >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Eli L. Diamond, MD, PhD diamonel@mskcc.org Principal Investigator: Eli L. Diamond, MD, PhD Sub-Investigator: Omar Abdel-Wahab, MD France AP-HP, Groupe Hospitalier Pitié-Salpêtrière Recruiting Paris, France, 75013 Contact: Julien Haroche, MD, PhD +33 1 42 17 80 37 julien.haroche@psl.aphp.fr Contact: Fleur Cohen Aubart, MD, PhD +33 1 42 17 82 42 fleur.cohen@psl.aphp.fr Principal Investigator: Julien Haroche, MD, PhD Sub-Investigator: Fleur Cohen Aubart, MD, PhD Sub-Investigator: Zahir Amoura, MD, MSc Collapse << |
| NCT01271803 | Malignant Melanoma | Phase 1 | Completed | - | United States, California ... more >> UCLA Department of Medicine Los Angeles, California, United States, 90024 University of California at San Francisco San Francisco, California, United States, 94115 The Angeles Clinic and Research Institute, Santa Monica Office Santa Monica, California, United States, 90025 United States, Colorado University of Colorado; Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University - Department of Medicine, Division of Gastroenterology/Hepatology Indianapolis, Indiana, United States, 46202 United States, Michigan Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building Detroit, Michigan, United States, 48201 United States, New York New York University Medical Center New York, New York, United States, 10036 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Australia, Victoria Peter Maccallum Cancer Institute; Medical Oncology Melbourne, Victoria, Australia, 3000 Collapse << |
| NCT01143753 | Neoplasms | Phase 1 | Completed | - | Australia, South Australia ... more >> Royal Adelaide Hospital; Oncology Adelaide, South Australia, Australia, 5000 Australia, Victoria Austin Hospital; Medical Oncology Heidelberg, Victoria, Australia, 3084 Royal Melbourne Hospital; Hematology and Medical Oncology Parkville, Victoria, Australia, 3052 Denmark Rigshospitalet, Onkologisk Klinik København Ø, Denmark, 2100 Spain Hospital Univ Vall d'Hebron; Servicio de Oncologia Barcelona, Spain, 08035 Collapse << |
| NCT02281214 | Lung Cancer | Not Applicable | Recruiting | November 17, 2018 | France ... more >> Centre Georges François Leclerc Recruiting Dijon, France, 21000 Contact: Emilie REDERSTORFF, PhD ERederstorff@cgfl.fr Contact: Sandrine TIAGO stiago@cgfl.fr Principal Investigator: Bruno COUDERT, MD, PhD Collapse << |
| NCT01960023 | Colorectal Cancer | Phase 1 Phase 2 | Unknown | December 2016 | United States, Florida ... more >> University of Florida Gainesville, Florida, United States, 32610 MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Idaho Saint Luke's Mountain States Tumor Institute Boise, Idaho, United States, 83712 United States, Illinois Decatur Memorial Hospital Decatur, Illinois, United States, 62526 United States, Michigan Saint Joseph Mercy Hospital Ann Arbor, Michigan, United States, 48106 Henry Ford Health System Detroit, Michigan, United States, 48202 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 Novant Health Presbyterian Medical Center Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Allegheny General Hospital Pittsburgh, Pennsylvania, United States, 15215 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 Reading Hospital and Medical Center West Reading, Pennsylvania, United States, 19611 Collapse << |
| NCT02034110 | Cancer | Phase 2 | Active, not recruiting | June 29, 2020 | - |
| NCT01667419 | Melanoma | Phase 3 | Active, not recruiting | October 14, 2020 | - |
| NCT01840527 | - | - | Active, not recruiting | March 2019 | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Collapse << |
| NCT01941927 | Melanoma | Phase 2 | Unknown | May 2016 | United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, New York Memorial Sloan-Kettering Cancer Center New York City, New York, United States, 10065 Collapse << |
| NCT01673854 | - | - | Completed | - | - |
| NCT01673854 | Melanoma | Phase 2 | Completed | - | United States, California ... more >> Beverly Hills Cancer Center Beverly Hills, California, United States, 90211 United States, Florida Baptist Cancer Institute Jacksonville, Florida, United States, 32207 Orlando Health, Inc Orlando, Florida, United States, 32806 United States, Georgia Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New Mexico University Of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 United States, New York Mount Sinai School Of Medicine New York, New York, United States, 10029 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 Duke University Hospital Durham, North Carolina, United States, 27710 Dumc Durham, North Carolina, United States, 27710 United States, Ohio University Hospitals Of Cleveland Cleveland, Ohio, United States, 44106 University Hospitals Cleveland, Ohio, United States, 44106 Collapse << |
| NCT01271803 | - | - | Completed | - | - |
| NCT01280643 | Metastatic Colorectal Cancer | Not Applicable | Completed | - | United States, Pennsylvania ... more >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Collapse << |
| NCT01596140 | Advanced Cancer ... more >> Solid Tumor Collapse << | Phase 1 | Active, not recruiting | December 2020 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT00888134 | Adult Solid Neoplasm | Phase 2 | Completed | - | United States, Massachusetts ... more >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Massachusetts General Hospital Charlestown, Massachusetts, United States, 02129 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT02587650 | ALK Fusion Protein Expression ... more >> BRAF wt Allele Invasive Skin Melanoma MET Fusion Gene Positive NRAS wt Allele NTRK1 Fusion Positive NTRK2 Fusion Positive NTRK3 Fusion Positive RET Fusion Positive ROS1 Fusion Positive Stage III Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Collapse << | Phase 2 | Recruiting | September 30, 2020 | United States, California ... more >> UCSF Medical Center-Mount Zion Recruiting San Francisco, California, United States, 94115 Contact: Adil I. Daud 415-353-7392 adil.daud@ucsf.edu Principal Investigator: Adil I. Daud Collapse << |
| NCT03399487 | Non-small Cell Lung Cancer Har... more >>boring ROS1 Rearrangement Collapse << | Phase 2 | Not yet recruiting | October 2020 | - |
| NCT02721459 | Melanoma Skin... more >> Cancer Collapse << | Phase 1 | Active, not recruiting | December 2021 | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse << |
| NCT02202200 | Melanoma BRAF V600E/K Mutated ... more >> CDNKN2A Loss Defined Collapse << | Phase 1 Phase 2 | Unknown | August 2018 | France ... more >> Saint-Louis Hospital Recruiting Paris, France, 75010 Contact: Celeste Lebbe, MDPHD +33 1 42 49 49 49 celeste.lebbe@sls.aphp.fr Principal Investigator: celeste lebbe, MD-PHD Collapse << |
| NCT03585686 | Langerhans Cell Histiocytosis | Phase 2 | Recruiting | December 2020 | Russian Federation ... more >> Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Recruiting Moscow, Russian Federation, 117997 Contact: Zhanna Shekhovtsova, MD 4956647078 ext 7538 zhanna.shekhovtsova@fccho-moscow.ru Contact: Eugene Pashanov, PhD +79262205578 e.pashanov@gmail.com Sub-Investigator: Dmitry Evseev, MD Principal Investigator: Michael Maschan, PhD Collapse << |
| NCT01667419 | - | - | Active, not recruiting | - | - |
| NCT02068079 | Melanoma | Phase 1 | Withdrawn(Study is being revis... more >>ed) Collapse << | - | United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse << |
| NCT03455764 | Melanoma | Phase 1 Phase 2 | Recruiting | September 30, 2025 | United States, Massachusetts ... more >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Jennifer A Maattala 617-632-3992 jennifera_maattala@dfci.harvard.edu Principal Investigator: Elizabeth I Buchbinder, MD Collapse << |
| NCT00888134 | - | - | Completed | - | - |
| NCT01841463 | Advanced or Inoperable Maligna... more >>nt Melanoma With BRAF Mutation Collapse << | Phase 1 | Suspended(Sponsor decision not... more >> related to patient safety) Collapse << | March 2016 | United States, California ... more >> UCSF Medical Center at Mount Zion South San Francisco, California, United States, 94115 United States, Colorado University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 United States, District of Columbia Georgetown-Lombardi Comprehensive Cancer Ctr Washington, District of Columbia, United States, 20057 United States, Texas The University of Texas, MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT01543698 | Solid Tumors Harboring a BRAF ... more >>V600 Mutation Collapse << | Phase 1 Phase 2 | Active, not recruiting | July 31, 2019 | United States, Florida ... more >> H. Lee Moffitt Cancer Center & Research Institute Moffitt SC 2 Tampa, Florida, United States, 33612 United States, Maryland The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Johns Hopkins Baltimore, Maryland, United States, 21287-0013 United States, Massachusetts Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02115 United States, Texas University of Texas/MD Anderson Cancer Center MD Univ TX Houston, Texas, United States, 77030-4009 Australia, New South Wales Array BioPharma Investigative Site Camperdown, New South Wales, Australia, 2050 Array BioPharma Investigative Site North Sydney, New South Wales, Australia, 2060 Array BioPharma Investigative Site Westmead, New South Wales, Australia, 2145 Belgium Array BioPharma Investigative Site Leuven, Belgium, 3000 Canada, Quebec Array BioPharma Investigative Site Montreal, Quebec, Canada, H3T 1E2 France Array BioPharma Investigative Site Paris, Cedex 10, France, 75475 Italy Array BioPharma Investigative Site Milano, MI, Italy, 20162 Array BioPharma Investigative Site Napoli, Italy, 80131 Singapore Array BioPharma Investigative Site Singapore, Singapore, 169610 Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Array BioPharma Investigative Site Madrid, Spain, 28050 Switzerland Array BioPharma Investigative Site St. Gallen, Switzerland, 9007 Array BioPharma Investigative Site Zuerich, Switzerland, 8091 Collapse << |
| NCT02308553 | Cutaneous Malignant Melanoma | Phase 1 Phase 2 | Recruiting | June 2018 | Germany ... more >> University Hospital Essen Recruiting Essen, NRW, Germany, 45147 Contact: Dirk Schadendorf, Prof. Dr. +49-201- 723 ext 4342 dirk.schadendorf@uk-essen.de Principal Investigator: Dirk Schadendorf, Prof. Dr. Elbeklinikum Buxtehude Recruiting Buxtehude, Germany, 21614 Contact: Peter Mohr, Dr. med. peter.mohr@elbekliniken.de Principal Investigator: Peter Mohr, Dr. med. SRH Wald-Klinikum Gera Not yet recruiting Gera, Germany, 07548 Contact: Martin Kaatz, PD Dr. martin.kaatz@wkg.srh.de Principal Investigator: Martin Kaatz, PD Dr. National Centre for Tumour Diseases (NCT) Recruiting Heidelberg, Germany, 69120 Contact: Jessica Hassel, Dr. med. jessica.hassel@med.uni-heidelberg.de Principal Investigator: Jessica Hassel, Dr. med. Universitätsklinikum des Saarlandes Not yet recruiting Homburg, Germany, 66421 Contact: Claudia Pföhler, PD Dr. claudia.pfoehler@uks.eu Principal Investigator: Claudia Pföhler, PD Dr. Klinikum der Stadt Ludwigshafen am Rhein gGmbH Recruiting Ludwigshafen, Germany, 67063 Contact: Edgar Dippel, Prof. Dr. dippele@klilu.de Principal Investigator: Edgar Dippel, Prof. Dr. Universitätsklinikum Schleswig-Holstein, Campus Lübeck Not yet recruiting Lübeck, Germany, 23538 Contact: Patrick Terheyden, PD Dr. patrick.terheyden@uksh.de Principal Investigator: Patrick Terheyden, PD Dr. University Hospital München Recruiting München, Germany, 80337 Contact: Carola Berking, Prof. Dr. carola.berking@med.uni-muenchen.de Principal Investigator: Carola Berking, Prof. Dr. Fachklinik Hornheide Recruiting Münster, Germany, 48157 Contact: Michael Fluck, Dr. med. michael.fluck@fachklinik-hornheide.de Principal Investigator: Michael Fluck, Dr. med. Collapse << |
| NCT02257424 | Advanced BRAF Mutant Melanoma | Phase 1 Phase 2 | Recruiting | - | United States, Pennsylvania ... more >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ravi Amaravadi, MD 877-204-9213 PennCancerTrials@emergingmed.com Principal Investigator: Ravi Amaravadi, MD Collapse << |
| NCT03101254 | Melanoma | Phase 1 Phase 2 | Recruiting | October 30, 2023 | United States, Massachusetts ... more >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Elizabeth Buchcinder, MD 617-632-5055 Principal Investigator: Elizabeth Buchbinder, MD Collapse << |
| NCT01748149 | Pediatric Recurrent/Refractory... more >> BRAFV600E-mutant Gliomas Collapse << | Early Phase 1 | Active, not recruiting | June 2020 | - |
| NCT01989585 | BRAF V600E Mutation Present ... more >> BRAF V600K Mutation Present Metastatic Melanoma Solid Neoplasm Stage III Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Collapse << | Phase 1 Phase 2 | Recruiting | - | United States, California ... more >> University of California Davis Comprehensive Cancer Center Suspended Sacramento, California, United States, 95817 United States, Massachusetts Massachusetts General Hospital Cancer Center Withdrawn Boston, Massachusetts, United States, 02114 United States, Missouri Siteman Cancer Center at West County Hospital Suspended Creve Coeur, Missouri, United States, 63141 Washington University School of Medicine Suspended Saint Louis, Missouri, United States, 63110 Siteman Cancer Center-South County Suspended Saint Louis, Missouri, United States, 63129 Siteman Cancer Center at Christian Hospital Suspended Saint Louis, Missouri, United States, 63136 Siteman Cancer Center at Saint Peters Hospital Suspended Saint Peters, Missouri, United States, 63376 United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Site Public Contact 732-235-8675 Principal Investigator: Janice M. Mehnert United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Site Public Contact 888-275-3853 Principal Investigator: James L. Abbruzzese United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu Principal Investigator: Kari L. Kendra United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact 877-312-3961 Principal Investigator: Michael A. Davies Collapse << |
| NCT02313012 | Neoplasm Metastasis | Phase 1 | Terminated(The MTD did not off... more >>er a sufficiently encouraging profile to proceed with the additional dosing schedule or to the cohort expansion phase.) Collapse << | - | United States, California ... more >> Cedars Sinai Medical Center, Inflammatory Bowel Disease Center Los Angeles, California, United States, 90048 United States, Connecticut Smilow Cancer Center New Haven, Connecticut, United States, 06510 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 Australia Peter MacCallum Cancer Centre East Melbourne, Australia, 3002 Collapse << |
| NCT01954043 | Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> GSK Investigational Site Goodyear, Arizona, United States, 85338 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75201 United States, Washington GSK Investigational Site Tacoma, Washington, United States, 98405 Australia, Victoria GSK Investigational Site Heidelberg, Victoria, Australia, 3084 GSK Investigational Site Melbourne, Victoria, Australia, 3004 United Kingdom GSK Investigational Site London, United Kingdom, W1G 6AD Collapse << |
| NCT03743298 | Metastatic Melanoma | Phase 1 | Not yet recruiting | January 2023 | - |
| NCT01264380 | - | - | Completed | - | - |
| NCT01657591 | Melanoma | Phase 1 | Active, not recruiting | June 2019 | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse << |
| NCT02626065 | Metastatic Melanoma | Phase 4 | Active, not recruiting | April 2018 | France ... more >> Centre Hospitalier Lyon Sud Pierre Benite, France, 69310 Collapse << |
| NCT03363217 | Low-grade Glioma ... more >> Plexiform Neurofibroma Central Nervous System Glioma Collapse << | Phase 1 Phase 2 | Recruiting | December 1, 2026 | Canada, Alberta ... more >> Alberta Children's Hospital Not yet recruiting Calgary, Alberta, Canada, T3B 6A8 Contact: Lucie Lafay-Cousin, MD 1 403-955-2554 lucie.lafay-cousin@ahs.ca Contact: Pina Giuliano 1-403-955-7269 pina.giuliano@ahs.ca Principal Investigator: Lucie Lafay-Cousin, MD Canada, Ontario The Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G 1X8 Contact: Ruben Machado, MSc (416) 813-7654 ext 203204 ruben.machado@sickkids.ca Principal Investigator: Eric Bouffet, MD Sub-Investigator: Uri Tabouri, MD Canada, Quebec CHU Sainte-Justine Recruiting Montreal, Quebec, Canada, H3T 1C5 Contact: Linda Hershon 1-(514)-345-4931 ext 5899 linda.hershon@recherche-ste-justine.qc.ca Principal Investigator: Sébastien Perreault, MD Montreal Children's Hospital Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Genevieve Legault, MD 1-(514)-412-4466 genevieve.legault4@mcgill.ca Principal Investigator: Genevieve Legault, MD Sub-Investigator: Nada Jabado, MD CHU de Québec Recruiting Quebec City, Quebec, Canada, G1V 4G2 Contact: Pana Giannakouros, MSc 1(418) 525-4444 ext 71671 panagiota.giannak@crchudequebec.ulaval.ca Contact: Valerie Larouche, MD 1(418) 525-4444 Valerie.Larouche@mail.chudequebec.ca Principal Investigator: Valerie Larouche, MD Collapse << |
| NCT01362296 | Lung Cancer, Non-Small Cell | Phase 2 | Completed | - | - |
| NCT01264380 | Malignant Melanoma | Phase 1 | Completed | - | United States, California ... more >> La Jolla, California, United States, 92037 Los Angeles, California, United States, 90095-1752 San Francisco, California, United States, 94115-1705 United States, Colorado Aurora, Colorado, United States, 80045 United States, Indiana Indianapolis, Indiana, United States, 46202 United States, Iowa Iowa City, Iowa, United States, 52242 United States, New Hampshire Lebanon, New Hampshire, United States, 03756 United States, South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Nashville, Tennessee, United States, 37232 United States, Texas Dallas, Texas, United States, 75246 Collapse << |
| NCT01362296 | - | - | Completed | - | - |
| NCT01940809 | BRAF V600E Mutation Present ... more >> BRAF V600K Mutation Present Metastatic Melanoma Stage III Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Collapse << | Phase 1 | Active, not recruiting | - | United States, Massachusetts ... more >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Collapse << |
| NCT01787500 | Advanced Cancers | Phase 1 | Active, not recruiting | February 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT01876641 | Metastatic Melanoma ... more >> Melanoma BRAF-mutated Metastatic Melanoma V600EBRAF-mutated Metastatic Melanoma Collapse << | Phase 1 | Terminated(Loss of funding) | - | United States, Iowa ... more >> University of Iowa Hospitals & Clinics Iowa City, Iowa, United States, 52242 Collapse << |
| NCT02561533 | Papillary Thyroid Carcinoma | Not Applicable | Completed | - | Denmark ... more >> Aarhus University Hospital Aarhus C, Denmark, 8000 Collapse << |
| NCT02610361 | Solid Tumors | Phase 1 | Completed | - | Australia, New South Wales ... more >> Chris O'Brien Lifehouse Camperdown, New South Wales, Australia, 2050 North Coast Cancer Institute Port Macquarie, New South Wales, Australia, 2444 Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Westmead Hospital Westmead, New South Wales, Australia, 2145 Australia, Queensland Tasman Oncology Research Ltd Southport, Queensland, Australia, 4215 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 The Queen Elizabeth Hospital Woodville South, South Australia, Australia, 5011 Australia, Victoria Box Hill Hospital Box Hill, Victoria, Australia, 3128 Monash Medical Centre Clayton, Victoria, Australia, 3168 Austin Health Heidelberg, Victoria, Australia Cabrini Hospital Malvern, Victoria, Australia, 3144 The Alfred Hospital Melbourne, Victoria, Australia, 3004 Peter MacCallum Cancer Centre Melbourne, Victoria, Australia Royal Melbourne Hospital Parkville, Victoria, Australia Australia, Western Australia Linear Clinical Research Limited Nedlands, Western Australia, Australia, 6009 New Zealand Christchurch Hospital Christchurch, New Zealand, 8011 Dunedin Public Hospital Dunedin, New Zealand, 9106 Waikato Hospital Hamilton, New Zealand Wellington Hospital Wellington, New Zealand Collapse << |
| NCT01262963 | Cancer | Phase 1 | Completed | - | United States, Washington ... more >> GSK Investigational Site Tacoma, Washington, United States, 98418 Collapse << |
| NCT03457896 | Metastatic Colorectal Cancer | Phase 2 | Recruiting | January 2021 | United States, California ... more >> Kaiser Permanente-Anaheim Recruiting Anaheim, California, United States, 92806 Kaiser Permanente-Baldwin Recruiting Baldwin Park, California, United States, 91706 Kaiser Permanente-Bellflower Recruiting Bellflower, California, United States, 90706 Kaiser Permanente-Fontana Recruiting Fontana, California, United States, 92335 Kaiser Permanente-Harbor City Recruiting Harbor City, California, United States, 90710 Kaiser Permanente-Irvine Recruiting Irvine, California, United States, 92618 Kaiser Permanente-Sunset Recruiting Los Angeles, California, United States, 90027 Kaiser Permanente-West Los Angeles (Cadillac) Recruiting Los Angeles, California, United States, 90034 Kaiser Permanente-Panorama City Recruiting Panorama City, California, United States, 91402 Kaiser Permanente-Riverside Recruiting Riverside, California, United States, 92505 Kaiser Permanente-Medical Group Recruiting San Diego, California, United States, 92108 Kaiser Permanente-Zion Recruiting San Diego, California, United States, 92120 Kaiser Permanente-San Marcos Recruiting San Marcos, California, United States, 92078 Kaiser Permanente-Woodland Hills Recruiting Woodland Hills, California, United States, 91367 United States, Florida UF Health Davis Cancer Pavilion and Shands Medical Plaza Recruiting Gainesville, Florida, United States, 32608 University of Florida Recruiting Gainesville, Florida, United States, 32610 United States, Illinois Cancer Care Specialists of Central IL-Decatur Recruiting Decatur, Illinois, United States, 62526 Decatur Memorial Hospital Recruiting Decatur, Illinois, United States, 62526 Crosslands Cancer Center Recruiting Effingham, Illinois, United States, 62401 Cancer Care Specialists of Central IL-Swansea Recruiting Swansea, Illinois, United States, 62226 United States, Michigan Trinity Health Michigan Recruiting Ann Arbor, Michigan, United States, 48106 Bronson Battle Creek Recruiting Battle Creek, Michigan, United States, 49017 St. Joseph Mercy Brighton Recruiting Brighton, Michigan, United States, 48114 St. Joseph Mercy Canton Recruiting Canton, Michigan, United States, 48188 St. Joseph Mercy Chelsea Recruiting Chelsea, Michigan, United States, 48118 Cancer Research Consortium of West Michigan Recruiting Grand Rapids, Michigan, United States, 49503-2560 Spectrum Health Butterworth Recruiting Grand Rapids, Michigan, United States, 49503 St. Mary Mercy Hospital Recruiting Livonia, Michigan, United States, 48154 Mercy Health Mercy Campus Recruiting Muskegon, Michigan, United States, 49444 St. Mary's of Michigan Recruiting Saginaw, Michigan, United States, 48601 Lakeland Healthcare-Marie Yeager Cancer Center Recruiting Saint Joseph, Michigan, United States, 49085 Metro Health Hospital Recruiting Wyoming, Michigan, United States, 49519 United States, Tennessee Wellmont Cancer Institute Recruiting Johnson City, Tennessee, United States, 37601 Wellmont Cancer Institute Recruiting Kingston, Tennessee, United States, 37660 United States, Virginia Wellmont Medical Associates-Oncology and Hematology Recruiting Bristol, Virginia, United States, 24201 Southwest Virginia Regional Cancer Center Recruiting Norton, Virginia, United States, 24273 Collapse << |
| NCT01910181 | Malignant Melanoma | Phase 1 | Completed | - | China ... more >> Beijing Cancer Hospital Beijing, China, 100142 Sun Yet-sen University Cancer Center Guangzhou, China, 510060 Collapse << |
| NCT03580382 | Melanoma | Phase 1 Phase 2 | Recruiting | April 2022 | United States, New York ... more >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Jennifer Tiao 929-455-2437 Jennifer.Tiao@nyumc.org Principal Investigator: Jeffrey Weber, MD Collapse << |
| NCT01910181 | - | - | Completed | - | - |
| NCT02961283 | Neoplasms Mel... more >>anoma Colorectal Neoplasm Carcinoma, Non-small Cell Lung Collapse << | Phase 1 | Active, not recruiting | December 2020 | United States, California ... more >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan START MidWest Grand Rapids, Michigan, United States, 49503 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Collapse << |
| NCT01959633 | Melanoma | Phase 1 Phase 2 | Recruiting | December 2017 | Italy ... more >> Fondazione G.Pascale Recruiting Napoli, Italy, 80131 Principal Investigator: Paolo A Ascierto Collapse << |
| NCT01693419 | Pancreas Neoplasms | Phase 2 | Completed | - | Korea, Republic of ... more >> Hallym University Medical Center Anyang, Korea, Republic of Collapse << |
| NCT01754376 | Melanoma | Phase 2 | Terminated(changes in availabl... more >>e treatments for melanoma) Collapse << | - | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02113 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Collapse << |
| NCT02281760 | BRAF V600E Mutation | Phase 2 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
| NCT01754376 | - | - | Terminated(changes in availabl... more >>e treatments for melanoma) Collapse << | - | - |
| NCT00422448 | Nevi | Not Applicable | Completed | - | Austria ... more >> Department of Dermatology, Medical University of Graz Graz, Austria, 8036 Collapse << |
| NCT01713972 | Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse << | Phase 1 | Active, not recruiting | December 31, 2019 | United States, Ohio ... more >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Texas University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT01231568 | Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84112 Collapse << |
| NCT02608034 | Metastatic Melanoma, BRAF V600... more >> Mutation Positive Collapse << | Phase 1 | Active, not recruiting | January 8, 2019 | United States, Kansas ... more >> University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States, 66205 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75230 Israel Rambam Health Care Campus; Oncology Haifa, Israel, 3109601 Hadassah Ein Karem Hospital; Oncology Dept Jerusalem, Israel, 9112001 Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 03080 Samsung Medical Center; Gastroenterology Seoul, Korea, Republic of, 135-710 Asan Medical Center; Division of Oncology Seoul, Korea, Republic of, 138-736 Severance Hospital - Yonsei Uni ; Obstetrics & Gynaecology Dept. Seoul, Korea, Republic of Russian Federation Republican Clinical Oncologic Dispensary of Republic Of Tatarstan Kazan, Russian Federation, 420029 FSBSI "N. N. Blokhin Russian Cancer Research Center" Moscow, Russian Federation, 115478 St. Petersburg Oncology Hospital St Petersburg, Russian Federation, 198255 Collapse << |
| NCT01086267 | Colorectal Cancer | Phase 1 Phase 2 | Completed | - | United States, Arizona ... more >> Oncology Research Associates D/B/A Scottsdale, Arizona, United States, 85258 United States, California Usc Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Canada, Ontario Local Institution Ottawa, Ontario, Canada, K1H 1C3 Collapse << |
| NCT02729298 | Advanced Solid Tumors ... more >> EGFR Positive Non-small Cell Lung Cancer Colorectal Carcinoma Recurrent Ovarian Carcinoma BRAF-Mutated Melanoma Collapse << | Phase 1 | Recruiting | September 2019 | United States, Arizona ... more >> Mayo Clinic Arizona Recruiting Phoenix, Arizona, United States, 85054 Contact: Debbie Gallagher, RN gallagher.deborah@mayo.edu Principal Investigator: Mahesh Seetharam, MD HonorHealth Research Institute Recruiting Scottsdale, Arizona, United States, 85258 Contact: Joyce Schaffer, RN 480-323-1339 clinicaltrials@honorhealth.com Principal Investigator: Vivek Khemka, MD United States, Florida Mayo Clinic Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Torsak Vimoktayon, MPH vimoktayon.torsak@mayo.edu Principal Investigator: YanYan Lou, MD United States, Minnesota Mayo Clinic Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Danielle Sommerfeldt sommerfeldt.danielle@mayo.edu Principal Investigator: Alex Adjei, MD United States, Texas University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Yolanda Pitts yolanda.pitts@utsouthwestern.edu Principal Investigator: Muhammad Beg, MD University of Texas Science Center at San Antonio (UTHSCSA) Recruiting San Antonio, Texas, United States, 78229 Contact: CTRC 210-450-2872 Principal Investigator: John Sarantopoulos, MD Collapse << |
| NCT02456701 | Thyroid Cancer | Phase 1 | Completed | - | United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT00422448 | - | - | Completed | - | - |
| NCT03178851 | Malignant Melanoma | Phase 1 | Recruiting | December 22, 2020 | - |
| NCT01777776 | Locally Advanced Metastatic BR... more >>AF Mutant Melanoma Collapse << | Phase 1 Phase 2 | Terminated(Study was withdrawn... more >> due to scientific and business considerations.) Collapse << | - | United States, Colorado ... more >> University of Colorado Dept of Oncology Aurora, Colorado, United States, 80045 United States, Michigan Karmanos Cancer Institute Dept of Oncology Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center Dept Oncology NY, New York, United States, 90033 United States, Oregon Oregon Health & Science University Dept. of OHSU (3) Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt University Medical Center SC - Dept of Oncology . Nashville, Tennessee, United States, 37232 Australia, New South Wales Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, South Australia Novartis Investigative Site Woodville, South Australia, Australia, 5011 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2X 3J4 Netherlands Novartis Investigative Site Utrecht, Netherlands, 3584CX Collapse << |
| NCT01750918 | Cancer | Phase 2 | Active, not recruiting | April 30, 2019 | United States, Arizona ... more >> Novartis Investigative Site Scottsdale, Arizona, United States, 85259 United States, California Novartis Investigative Site San Francisco, California, United States, 94115 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, New York Novartis Investigative Site New York, New York, United States, 10065 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Paris cedex 12, France, 75571 Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Milano, Lombardia, Italy, 20162 Novartis Investigative Site Candiolo (TO), Piemonte, Italy, 10060 Japan Novartis Investigative Site Aichi, Japan, 464-8681 Novartis Investigative Site Chiba, Japan, 277-8577 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Utrecht, Netherlands, 3584 CX Spain Novartis Investigative Site Barcelona, Spain, 08035 United Kingdom Novartis Investigative Site Birmingham, United Kingdom, B15 2TH Collapse << |
| NCT01512251 | BRAF Mutant Metastatic Melanom... more >>a Collapse << | Phase 1 Phase 2 | Completed | - | United States, California ... more >> University of California, San Francisco San Francisco, California, United States, 94115 Collapse << |
| NCT02428712 | Advanced Unresectable Solid Tu... more >>mors BRAF-mutated Tumors Collapse << | Phase 1 Phase 2 | Active, not recruiting | April 2020 | United States, Arizona ... more >> HonorHealth Scottsdale, Arizona, United States, 85258 United States, California University of California, San Francisco San Francisco, California, United States, 94143 Stanford Hospitals and Clinics Stanford, California, United States, 94305 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania Thomas Jefferson University Medical Oncology Clinica Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Hospital (Baylor College of Medicine) Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Collapse << |
| NCT02027961 | Melanoma | Phase 1 Phase 2 | Completed | - | United States, Arizona ... more >> Research Site Scottsdale, Arizona, United States, 85258 United States, California Research Site Los Angeles, California, United States, 90095 Research Site San Francisco, California, United States, 94143 United States, Florida Research Site Miami Beach, Florida, United States, 33140 United States, Illinois Research Site Chicago, Illinois, United States, 60611 United States, Massachusetts Research Site Boston, Massachusetts, United States, 02114 United States, Missouri Research Site Saint Louis, Missouri, United States, 63110 Canada, Ontario Research Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Research Site Montreal, Quebec, Canada, H3A 1A1 France Research Site Villejuif cedex, France, 94805 Italy Research Site Napoli, Italy, 80131 Collapse << |
| NCT02902042 | Malignant Melanoma | Phase 1 Phase 2 | Recruiting | March 2022 | Germany ... more >> Universitätsklinikum Freiburg Active, not recruiting Freiburg, Baden-Württemberg, Germany, 79106 Klinikum Augsburg Süd Not yet recruiting Augsburg, Bavaria, Germany, 86179 Principal Investigator: Christiane Pfeiffer, PD Dr. med. Klinikum rechts der Isar Recruiting München, Bavaria, Germany, 81675 Principal Investigator: Angela Krackhardt, Prof.Dr.med. Klinikum Nürnberg Nord Recruiting Nürnberg, Bavaria, Germany, 90419 Principal Investigator: Erwin S. Schultz, Prof.Dr.med. Vivantes Klinikum im Friedrichshain Active, not recruiting Berlin Friedrichshain, Berlin, Germany, 10249 Universitätsklinikum der RWTH Aachen Not yet recruiting Aachen, Nordrhein-Westfalen, Germany, 52074 Principal Investigator: Albert Rübben, Prof.Dr.med. University Hospital Essen, Department of Dermatology, Skin Cancer Center Recruiting Essen, North Rhine-Westphalia, Germany, 45122 Contact: Dirk Schadendorf, Prof. Dr. +49 (0) 201-723 ext 4342 dirk.schadendorf@uk-essen.de Principal Investigator: Dirk Schadendorf, Prof. Dr. Sub-Investigator: Lisa Zimmer, Dr. med. Sub-Investigator: Elisabeth Livingstone, Dr. med. HELIOS Klinikum Krefeld Recruiting Krefeld, North Rhine-Westphalia, Germany, 47805 Principal Investigator: Chalid Assaf, PD Dr. med. Gesellschaft für Klinische Forschung Ludwigshafen mbH Not yet recruiting Ludwigshafen am Rhein, Rheinland-Pfalz, Germany, 67063 Principal Investigator: Edgar Dippel, Prof.Dr.med. Städtisches Klinikum Dessau Recruiting Dessau, Saxony-Anhalt, Germany, 06847 Principal Investigator: Dietrich Trebing, Dr. med. Collapse << |
| NCT01512251 | - | - | Completed | - | - |
| NCT00880321 | Cancer | Phase 1 | Completed | - | United States, California ... more >> GSK Investigational Site Los Angeles, California, United States, 90025 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Collapse << |
| NCT02097225 | BRAF V600E Mutation Present ... more >> BRAF V600K Mutation Present Metastatic Malignant Solid Neoplasm Metastatic Melanoma Stage III Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Unresectable Solid Neoplasm Collapse << | Phase 1 | Recruiting | - | United States, Massachusetts ... more >> Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Ryan J. Sullivan 617-724-4000 rsullivan7@partners.org Principal Investigator: Ryan J. Sullivan Dana-Farber Cancer Institute Suspended Boston, Massachusetts, United States, 02215 Collapse << |
| NCT01767623 | Neoplasms | Phase 1 | Completed | - | United States, California ... more >> California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States, 92008 Australia, Victoria Peninsula and South Eastern Haematology and Oncology Grou Frankston, Victoria, Australia, 3199 Greece District General Hospital of Athens Laiko; 1st Internal Medicine Clinic Athens, Greece, 11527 Israel Rambam Health Care Campus Haifa, Israel, 31096 Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Russian Federation SBIH " Clinical Oncological Dispensary # 1"; Chemotherapy department #1 and #2 Krasnodar, Russian Federation, 350040 Turkey Ege University Medicine Develoment and Pharmacokinetics Research Center; Pulmonary Diseases Izmir, Turkey, 35040 United Kingdom Velindre Cancer Centre Cardiff, United Kingdom, CF14 2TL Collapse << |
| NCT01767454 | Solid Tumours | Phase 1 | Completed | - | United States, California ... more >> GSK Investigational Site Los Angeles, California, United States, 90025 GSK Investigational Site San Francisco, California, United States, 94115 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02215 United States, Missouri GSK Investigational Site Saint Louis, Missouri, United States, 63110 United States, New York GSK Investigational Site New York, New York, United States, 10065 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Collapse << |
| NCT01777776 | - | - | Terminated(Study was withdrawn... more >> due to scientific and business considerations.) Collapse << | - | - |
| NCT03332589 | Malignant Melanoma ... more >> Brain Metastases Collapse << | Phase 1 | Recruiting | June 30, 2021 | United States, Arizona ... more >> University of Arizona Cancer Center Recruiting Tucson, Arizona, United States, 85724 Contact: Crystal Placencia, BS 520-694-1231 cplacencia@uacc.arizona.edu Principal Investigator: Hani Babiker, MD Collapse << |
| NCT01531361 | Advanced Malignant Neoplasm ... more >> BRAF Gene Mutation Metastatic Malignant Neoplasm Recurrent Malignant Neoplasm Refractory Malignant Neoplasm Collapse << | Phase 1 | Active, not recruiting | February 28, 2020 | United States, Texas ... more >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT02768207 | Metastatic Melanoma | Phase 2 | Active, not recruiting | July 30, 2019 | Belgium ... more >> UZ Brussel Brussel, Belgium, 1090 Institut Jules Bordet Bruxelles, Belgium, 1000 CHIREC Edith Cavell Bruxelles, Belgium, 1180 UZ Antwerpen Edegem, Belgium, 2650 UZ Gent Gent, Belgium, 9000 Jessa Zkh (Campus Virga Jesse) Hasselt, Belgium, 3500 AZ Groeninge Kortrijk, Belgium, 8500 Clinique Ste-Elisabeth Namur, Belgium, 5000 AZ Delta (Campus Wilgenstraat) Roeselare, Belgium, 8800 AZ Nikolaas (Sint Niklaas) Sint Niklaas, Belgium, 9100 Sint Augustinus Wilrijk Wilrijk, Belgium, 2610 Poland Centrum Onkologii Instytut Klinika Nowotworow Ukladowych i Uogolnionych Krakow, Poland Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu. Poznań, Poland, 60-355 Centrum Onkologii- Instytut; im. M.Skłodowskiej-Curie Warszawa, Poland, 02-781 Collapse << |
| NCT01225536 | Solid Tumor | Phase 1 | Completed | - | United States, California ... more >> Los Angeles, California, United States, 90025 United States, Connecticut New Haven, Connecticut, United States, 06520 United States, New Jersey New Brunswick, New Jersey, United States, 08903 Italy Rozzano, Italy, 20089 Collapse << |
| NCT02082665 | Cancer | Phase 1 | Completed | - | United States, New Hampshire ... more >> GSK Investigational Site Lebanon, New Hampshire, United States, 03756 Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Sevilla, Spain, 41013 Collapse << |
| NCT01677741 | Neoplasms, Brain | Phase 1 | Recruiting | September 2, 2019 | - |
| NCT01947023 | BRAF V600E Mutation Present ... more >> BRAF V600K Mutation Present Metastatic Thyroid Gland Carcinoma Unresectable Thyroid Gland Carcinoma Collapse << | Phase 1 | Active, not recruiting | - | United States, New York ... more >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT01400451 | - | - | Terminated(More than 2 of 6 pa... more >>tients treated experienced dose limiting toxicities.) Collapse << | - | - |
| NCT01400451 | Melanoma | Phase 1 | Terminated(More than 2 of 6 pa... more >>tients treated experienced dose limiting toxicities.) Collapse << | - | United States, California ... more >> University Of California Los Angeles Los Angeles, California, United States, 90095 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Dana Farber Cancer Inst Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT01983124 | Malignant Melanoma Stage IV | Phase 2 | Completed | - | Italy ... more >> Paola Queirolo Genova, Italy, 16132 Istituto Nazionale per lo Studio e la Cura dei Tumori "G.Pascale" Napoli, Italy, 80131 Collapse << |
| NCT01738451 | Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38120 GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84112-5550 Australia, Victoria GSK Investigational Site Heidelberg, Victoria, Australia, 3084 GSK Investigational Site Melbourne, Victoria, Australia, 3004 United Kingdom GSK Investigational Site London, United Kingdom, W1G 6AD Collapse << |
| NCT02138292 | Melanoma | Phase 1 | Completed | - | United States, Texas ... more >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Collapse << |
| NCT02902029 | Malignant Melanoma | Phase 2 | Recruiting | December 2021 | France ... more >> Hôpital Ambroise-Paré Recruiting Boulogne-Billancourt, France, 92104 Contact: Philippe Saiag, Prof. philippe.saiag@apr.aphp.fr Hospital Claude Huriez Not yet recruiting Lille, France, 59000 Contact: Laurent Mortier, Prof. laurent.mortier@chru-lille.fr Hôpital de la Timone Recruiting Marseille, France, 13885 Contact: Jean J Grob, Prof. jean-jacques.grob@ap-hm.fr CHU de Nantes Not yet recruiting Nantes, France, 44093 Contact: Brigitte Dreno, Prof. brigitte.dreno@wanadoo.fr Centre Hospitalier Lyon Sud Not yet recruiting Pierre-Bénite, France, 69310 Contact: Stéphane Dalle, Dr. stephane.dalle@chu-lyon.fr Germany SLK-Kliniken Heilbronn GmbH Recruiting Heilbronn, Baden-Wuerttemberg, Germany, 74078 Contact: Uwe Martens, Prof. Dr. uwe.martens@slk-kliniken.de Principal Investigator: Uwe Martens, Prof. Dr. Sub-Investigator: Jamil Akkad University Hospital Mannheim, Clinic for Dermatology Recruiting Mannheim, Baden-Wuerttemberg, Germany, 68167 Contact: Jochen Utikal, Prof. Dr. jochen.utikal@umm.de Principal Investigator: Jochen Utikal, Prof. Dr. Sub-Investigator: Maria Rita Gaiser, PD Dr. med. National Centre for Tumour Diseases (NCT) Recruiting Heidelberg, BW, Germany, 69120 Contact: Jessica Hassel, Dr. med. jessica.hassel@med.uni-heidelberg.de Principal Investigator: Jessica Hassel, Dr. med. Sub-Investigator: Martin Hartmann, Dr. med University Hospital Essen, Department of Dermatology, Skin Cancer Center Recruiting Essen, North Rhine-Westphalia, Germany, 45122 Contact: Dirk Schadendorf, Prof. Dr. dirk.schadendorf@uk-essen.de Principal Investigator: Dirk Schadendorf, Prof. Dr. Sub-Investigator: Elisabeth Livingstone, Dr. Sub-Investigator: Lisa Zimmer, Dr. HELIOS Klinikum Erfurt Recruiting Erfurt, Thuringia, Germany, 99089 Contact: Rudolf Herbst, Prof. Dr. rudolf.herbst@helios-kliniken.de Principal Investigator: Rudolf Herbst, Prof. Dr. Sub-Investigator: Ivonne Kellner, Dr. med. Charité-Universitätsmedizin Berlin Recruiting Berlin, Germany, 10117 Contact: Felix Kiecker, Dr. med. felix.kiecker@charite.de Principal Investigator: Felix Kiecker, Dr. med. Sub-Investigator: Claas Ulrich, Dr. med. Elbe Kliniken Stade - Buxtehude Not yet recruiting Buxtehude, Germany, 21614 Contact: Peter Mohr, Dr. med. Peter.Mohr@elbekliniken.de Principal Investigator: Peter Mohr, Dr. med. Universitätsklinik Dresden Recruiting Dresden, Germany, 01307 Contact: Friedegund Meier, Prof. Dr. friedegund.meier@uniklinikum-dresden.de Principal Investigator: Friedegund Meier, Prof. Dr. Sub-Investigator: Marlene Garzarolli Medizinische Hochschule Hannover Recruiting Hannover, Germany, 30625 Contact: Ralf Gutzmer, Prof. Dr. gutzmer.ralf@mh-hannover.de Principal Investigator: Ralf Gutzmer, Prof. Dr. Sub-Investigator: Imke Satzger, Pd Dr. Universitätsklinikum des Saarlandes Not yet recruiting Homburg/Saar, Germany, 66421 Contact: Claudia Pföhler, Prof. Dr. Claudia.Pfoehler@uniklinikum-saarland.de Principal Investigator: Claudia Pföhler, Prof. Dr. Sub-Investigator: Thomas Vogt, Prof. Dr. Universitäts-Hautklinik Kiel Recruiting Kiel, Germany, 24105 Contact: Katharina Kähler, Dr. med. kckaehler@yahoo.de Principal Investigator: Katharina Kähler, Dr. med. Sub-Investigator: Axel Hauschild, Prof. Dr. Universitätsklinikum Köln Not yet recruiting Köln, Germany, 50937 Contact: Cornelia Mauch, Prof. Dr. cornelia.mauch@uk-koeln.de Principal Investigator: Cornelia Mauch, Prof. Dr. Universitätsklinikum Leipzig Recruiting Leipzig, Germany, 04103 Contact: Jan Christoph Simon, Prof. Dr. jan.simon@medizin.uni-leipzig.de Principal Investigator: Jan Christoph Simon, Prof. Dr. Sub-Investigator: Mirjana Ziemer, Dr. med. Gesellschaft für Klinische Forschung Ludwigshafen mbH Recruiting Ludwigshafen, Germany, 67063 Contact: Edgar Dippel, Prof. Dr. dippele@klilu.de Principal Investigator: Edgar Dippel, Prof. Dr. Sub-Investigator: Evelyn Dabrowski, Dr. med. Universitätsklinikum Schleswig-Holstein Recruiting Lübeck, Germany, 23538 Contact: Patrick AM Terheyden, PD Dr. med. patrick.terheyden@uksh.de Principal Investigator: Patrick AM Terheyden, PD Dr. med. Sub-Investigator: Diamant Thaci, Prof. Universitätsklinikum Mainz Recruiting Mainz, Germany, 55131 Contact: Carmen Loquai, Prof. Dr. carmen.loquai@unimedizin-mainz.de Principal Investigator: Carmen Loquai, Prof. Dr. Sub-Investigator: Stephan Grabbe, Prof. Dr. Sub-Investigator: Heidrun Karin Mitzel-Rink, Dr. Johannes Wesling Klinikum Minden Recruiting Minden, Germany, 32429 Contact: Rudolf Stadler, Prof. Dr. rudolf.stadler@muehlenkreiskliniken.de Principal Investigator: Rudolf Stadler, Prof. Dr. Sub-Investigator: Jörg Böttjer, Dr. Klinikum der Universität München Recruiting München, Germany, 80337 Contact: Carola Berking, Prof. Dr. Carola.Berking@med.uni-muenchen.de Principal Investigator: Carola Berking, Prof. Dr. Sub-Investigator: Julia Katharina Tietze, Dr. med. Universitätsklinikum Tübingen Recruiting Tübingen, Germany, 72076 Contact: Claus Garbe, Prof. Dr. claus.garbe@med.uni-tuebingen.de Principal Investigator: Claus Garbe, Prof. Dr. Sub-Investigator: Thomas Kurt Eigentler, PD Dr. med. Sub-Investigator: Benjamin Matthias Weide, Dr. med. Uniklinikum Würzburg Recruiting Würzburg, Germany, 97080 Contact: Anja Heike Gesierich, MD Gesierich_A@ukw.de Principal Investigator: Anja Heike Gesierich, MD Sub-Investigator: Marion Wobser, Dr. Greece "LAIKO" General Hospital of Athens Recruiting Athens, Greece, 11527 Contact: Helen Gogas, Prof. hgogas@hol.gr Serbia Military Medical Academy Recruiting Belgrad, Serbia, 11000 Contact: Lidija Kandolf-Sekulovic, Prof. lkandolfsekulovic@gmail.com Collapse << |
| NCT02296203 | Metastatic Colorectal Cancer | Phase 2 | Active, not recruiting | June 15, 2018 | Italy ... more >> AUSL DI FROSINONE - FROSINONE (FR) ONCOLOGIA MEDICA U.O. Oncologia Medica Frosinone, Italy, 03100 Irccs Istituto Oncologico Veneto (Iov) - Padova (Pd) Oncologia Medica Padova, Italy, 35128 Azienda Ospedaliero Universitaria Di Parma - U.O.Oncologia Medica Parma, Italy A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica Pisa, Italy, 56126 AUSL 5 DI PISA - PISA (PI) ONCOLOGIA MEDICA oncologia medica Osp Lotti Pontedera Pontedera, Italy, 56100 Ospedale Fatebenefratelli Roma, Italy, 00186 Azienda Policlinico Umberto I - Oncologia Medica Roma, Italy Campus Biomedico Roma, Italy A.O. Universitaria S.Maria Della Misericordia Di Udine Udine, Italy, 33100 Collapse << |
| NCT03754179 | Melanoma | Phase 1 Phase 2 | Recruiting | December 1, 2020 | Belgium ... more >> UZ Brussel Recruiting Jette, Brabant, Belgium, 1090 Contact: Bart Neyns, Phd,Md 0032(0)2477 64 15 bart.neyns@uzbrussel.be Principal Investigator: Bart Neyns, Phd,Md Collapse << |
| NCT02441465 | Malignant Melanoma, Cancer | Phase 1 | Completed | - | Hungary ... more >> Magyar Honvedseg Egeszsegugyi Kozpont Budapest, Hungary, H-1134 Collapse << |
| NCT01826448 | V600-mutated BRAF Unresectable... more >> Melanoma V600-mutated BRAF Metastatic Melanoma Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF Inhibitor Collapse << | Phase 1 | Terminated | - | United States, California ... more >> UCLA Los Angeles, California, United States, 90024 United States, Colorado University of Colorado, Denver Aurora, Colorado, United States, 80012 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 France Institute Gustave Roussy Paris, France Germany University Hospital Essen Essen, Germany Collapse << |
| NCT02357732 | Metastatic Melanoma | Phase 1 | Withdrawn(PI decided not to pr... more >>oceed) Collapse << | - | - |
| NCT02906059 | Metastatic Colorectal Cancer | Phase 1 | Recruiting | September 2019 | United States, New York ... more >> Laura and Isaac Perlmutter Cancer Center Recruiting New York, New York, United States, 10016 Contact: Deirdre Cohen, MD 212-731-5656 Deirdre.Cohen@nyumc.org Sub-Investigator: Ping Gu, MD Sub-Investigator: Cynthia Leichman, MD Sub-Investigator: Lawrence Leichman, MD Sub-Investigator: Theresa Ryan, MD Sub-Investigator: Jennifer Wu, MD Collapse << |
| NCT03088176 | Melanoma BRAF... more >> Gene Mutation Collapse << | Phase 1 | Recruiting | June 30, 2021 | United States, Tennessee ... more >> West Cancer Center Recruiting Germantown, Tennessee, United States, 38138 Contact: Ari VanderWalde, MD, MPH 901-683-0055 ext 63015 avanderw@westclinic.com Contact: Nibedita Chakraborty 901-683-0055 ext 63023 nchakraborty@westclinic.com Collapse << |
| NCT02827565 | Metastatic Colorectal Cancer | Not Applicable | Completed | - | France ... more >> Institut de Cancerologie de Lorraine Vandoeuvre-lès-Nancy, France, 54500 Collapse << |
| NCT02967692 | Melanoma | Phase 3 | Recruiting | February 13, 2020 | - |
| NCT03042221 | - | - | Recruiting | April 30, 2019 | United States, Colorado ... more >> University of Colorado, Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Mary K Jackson 303-724-1650 mary.k.jackson@ucdenver.edu Contact: Terry NG, MD 303-724-2980 terry.ng@ucdenver.edu Principal Investigator: Terry ng, MD Collapse << |
| NCT01616199 | Advanced BRAF-mutant Cancers | Phase 1 Phase 2 | Terminated(slow accrual) | - | United States, Florida ... more >> H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, New York New York University New York, New York, United States, 10016 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Collapse << |
| NCT03132090 | Malignant Melanoma Stage IV | Not Applicable | Recruiting | June 2018 | Germany ... more >> Dept. of Radiology, University of Tuebingen Recruiting Tuebingen, Germany, 72076 Contact: Christina Pfannenberg, MD +49 7071 2982756 christina.pfannenberg@med.uni-tuebingen.de Contact: Brigitte Gueckel +49 7071 2981212 brigitte.gueckel@med.uni-tuebingen.de Collapse << |
| NCT03089268 | - | - | Active, not recruiting | January 2027 | Spain ... more >> Hospital Universitari i Politècnic La Fe Valencia, Spain, 46026 Collapse << |
| NCT00866177 | Recurrent Melanoma ... more >> Stage III Skin Melanoma Stage IV Skin Melanoma Collapse << | Phase 2 | Completed | - | United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT00866177 | - | - | Completed | - | - |
| NCT01820364 | - | - | Terminated(Study was withdrawn... more >> due to scientific and business considerations.) Collapse << | - | - |
| NCT01820364 | Melanoma | Phase 2 | Terminated(Study was withdrawn... more >> due to scientific and business considerations.) Collapse << | - | United States, Tennessee ... more >> Sarah Cannon Research Institute Onc Dept Nashville, Tennessee, United States, 37203 Australia, Victoria Novartis Investigative Site East Melbourne, Victoria, Australia, 3002 Canada, Alberta Novartis Investigative Site Edmonton, Alberta, Canada, T6G 1Z2 Germany Novartis Investigative Site Heidelberg, Germany, 69120 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Zuerich, Switzerland, 8091 Collapse << |
| NCT01505400 | - | - | Active, not recruiting | February 2020 | Canada, Ontario ... more >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse << |
| NCT02840409 | Low Grade Glioma | Phase 2 | Recruiting | August 2026 | Canada, Ontario ... more >> The Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G 1X8 Contact: Ute Bartels, MD 416-813-5249 ute.bartels@sickkids.ca Contact: Ruben Machado 416-813-7654 ext 203204 ruben.machado@sickkids.ca Sub-Investigator: Uri Tabori, MD Principal Investigator: Ute Bartels, MD Sub-Investigator: Annie Huang, MD Sub-Investigator: Vijay Ramaswamy, MD Collapse << |
| NCT01519791 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
| NCT02670707 | Langerhans Cell Histiocytosis | Phase 3 | Recruiting | January 2025 | United States, Texas ... more >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carl Allen, MD, PhD 832-826-0860 ceallen@txch.org Collapse << |
| NCT00577031 | - | - | Completed | - | - |
| NCT01519791 | - | - | Completed | - | - |
| NCT00577031 | Colorectal Cancer | Phase 4 | Completed | - | Italy ... more >> Bologna, Italy, 40138 Brescia, Italy, 25122 Cagliari, Italy, 09100 Cagliari, Italy, 09121 Caserta, Italy, 81100 Catanzaro, Italy, 88100 Cefalu, Italy, 90015 Fano, Italy, 61032 Firenze, Italy, 50139 Frattaminore, Italy, 80026 Grosseto, Italy, 58100 Ivrea, Italy, 10015 Latisana, Italy, 33053 Lecce, Italy, 73100 Legnago, Italy, 37045 Legnano, Italy, 20025 Macerata, Italy, 62100 Napoli, Italy, 80131 Negrar, Italy, 37024 Orbassano, Italy, 10043 Padova, Italy, 35128 Palermo, Italy, 90127 Palermo, Italy, 90146 Pavia, Italy, 27100 Reggio Calabria, Italy, 89100 Reggio Emilia, Italy, 42100 Rionero in Vulture, Italy, 85028 Roma, Italy, 00152 Roma, Italy, 00184 Roma, Italy, 00186 Roma, Italy, 00189 Salerno, Italy, 84131 San Giovanni Rotondo, Italy, 71013 Sondrio, Italy, 23100 Taormina, Italy, 98030 Torino, Italy, 10125 Torino, Italy, 10153 Verbania, Italy, 28921 Collapse << |
| NCT02083484 | - | - | - | - | - |
| NCT01765556 | Malignant Melanoma, Neoplasms | Phase 1 | Withdrawn | October 2013 | - |
| NCT03087071 | Colorectal Cancer | Phase 2 | Recruiting | December 2021 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact evilar@mdanderson.org Collapse << |
| NCT01351103 | Pancreatic Cancer ... more >> BRAF Mutant Colorectal Cancer Melanoma Triple Negative Breast Cancer Head and Neck Squamous Cell Cancer Cervical Squamous Cell Cancer Esophageal Squamous Cell Cancer Lung Squamous Cell Cancer Collapse << | Phase 1 | Recruiting | August 20, 2020 | United States, California ... more >> Novartis Investigative Site Recruiting Los Angeles, California, United States, 90024 United States, Maryland Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21287-0013 Contact: Ashley Elza O'Connor +1 410 502 2377 aoconnor@jhmi.edu Principal Investigator: Roisin Connolly United States, Massachusetts Dana Farber Cancer Institute SC Withdrawn Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute SC-7 Recruiting Boston, Massachusetts, United States, 02215 Contact: Marios Giannakis, M.D., Ph.D. 617-632-6805 Marios_Giannakis@dfci.harvard.edu Principal Investigator: Marios Giannakis, M.D., Ph.D. United States, Michigan University of Michigan Comprehensive Cancer Center Onc Dept. Not yet recruiting Ann Arbor, Michigan, United States, 48109-0944 Contact: Cancer AnswerLine 800-865-1125 Principal Investigator: David Smith Karmanos Cancer Institute Wayne St Recruiting Detroit, Michigan, United States, 48201 Contact: DeQuindalyn Moore 313-576-9371 moored@karmanos.org Principal Investigator: Ulka A. Vaishampayan United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson 2 Recruiting Houston, Texas, United States, 77030-4009 Contact: Stepanek M. Vanda 713-792-2921 vstepane@mdanderson.org Principal Investigator: Filip P. Janku Netherlands Novartis Investigative Site Recruiting Rotterdam, Netherlands, 3075 EA Novartis Investigative Site Recruiting Utrecht, Netherlands, 3584CX Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Novartis Investigative Site Recruiting Madrid, Spain, 28050 Collapse << |
| NCT01877811 | Solid Tumors | Phase 1 | Active, not recruiting | June 2019 | United States, California ... more >> City of Hope Duarte, California, United States University of California Irvine College of Medicine Irvine, California, United States University of California San Diego Moores Cancer Center San Diego, California, United States United States, District of Columbia Lombardi Comprehensive Cancer Center, Georgetown Washington, District of Columbia, United States United States, Florida Florida Cancer Center Sarasota, Florida, United States United States, Georgia University Cancer & Blood Center, LLC Athens, Georgia, United States United States, Massachusetts Massachusetts General Hospital/Beth Israel Deaconess Med. Ctr./Dana Farber Cancer Institute Boston, Massachusetts, United States United States, Michigan Henry Ford Health System Detroit, Michigan, United States Karmanos Cancer Center Detroit, Michigan, United States United States, Missouri Washington University Saint Louis, Missouri, United States United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States United States, Washington University of Washington, Seattle Cancer Care Alliance Seattle, Washington, United States Collapse << |
| NCT01262482 | Advanced or Metastatic Gastric... more >> or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) Collapse << | Phase 2 | Completed | - | Spain ... more >> Hospital Clinic de Barcelona Barcelona, Spain Hospital Sant Pau Barcelona, Spain H. Josep Trueta Girona, Spain Centro Oncológico M.D. Anderson Spain Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital La Paz Madrid, Spain Hospital Althaia Manresa, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital General de Valencia Valencia, Spain Collapse << |
| NCT02306850 | Unresectable Malignant Neoplas... more >>m Melanoma Metastatic Melanoma Stage IV Melanoma Stage III Melanoma Collapse << | Phase 2 | Recruiting | February 2019 | United States, Missouri ... more >> Saint Louis University Hospital Recruiting Saint Louis, Missouri, United States, 63101 Contact: Debra L King, RN 314-268-7061 richartstudy@gmail.com Principal Investigator: John M Richart, M.D. Collapse << |
| NCT03097601 | - | - | Active, not recruiting | December 30, 2019 | France ... more >> Centre Antoine LACASSAGNE Nice, France, 06189 Collapse << |
| NCT03732703 | Relapsed Refractory Multiple M... more >>yeloma Collapse << | Phase 1 Phase 2 | Not yet recruiting | February 10, 2024 | United States, Arizona ... more >> Mayo Clinic - Arizona Not yet recruiting Phoenix, Arizona, United States, 85054 United States, California City of Hope Not yet recruiting Duarte, California, United States, 91010 United States, Georgia Emory University Not yet recruiting Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Cancer Center Not yet recruiting Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Not yet recruiting Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Health System Not yet recruiting Ann Arbor, Michigan, United States, 48109 Karmanos Cancer Center Not yet recruiting Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic - Minnesota Not yet recruiting Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Division of Medical Oncology Not yet recruiting Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Not yet recruiting Hackensack, New Jersey, United States, 07610 United States, New York Mount Sinai School of Medicine Not yet recruiting New York, New York, United States, 10029 Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 United States, North Carolina Levine Cancer Institute Not yet recruiting Charlotte, North Carolina, United States, 28204 United States, Ohio Ohio State University College of Medicine Not yet recruiting Columbus, Ohio, United States, 43210 United States, Texas UT Southwestern Medical Center Not yet recruiting Dallas, Texas, United States, 75390 United States, Virginia Virginia Cancer Specialists Not yet recruiting Fairfax, Virginia, United States, 22031 Collapse << |
| NCT02645149 | Melanoma | Phase 4 | Not yet recruiting | August 2021 | Australia, New South Wales ... more >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez 612 9911 7200 maria.gonzalez@melanoma.org.au Principal Investigator: John Thompson Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez +612 9911 7200 maria.gonzalez@melanoma.org.au Contact: Alex Menzies +612 9911 7200 info@melanoma.org.au Sub-Investigator: Georgina Long Principal Investigator: Alex Menzies Collapse << |
| NCT02159066 | Melanoma | Phase 2 | Active, not recruiting | March 30, 2019 | United States, Arizona ... more >> Mayo Clinic - Arizona onc Dept Scottsdale, Arizona, United States United States, California University of California at Los Angeles Onc Dept Los Angeles, California, United States, 90095 United States, Massachusetts Massachusetts General Hospital Dept of Onc. Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center Dept Oncology New York, New York, United States, 90033 United States, Oregon Oregon Health & Science University Onc. Dept Portland, Oregon, United States, 97239 United States, Tennessee Sarah Cannon Research Institute Onc. Dept Nashville, Tennessee, United States, 37203 Australia, Victoria Array BioPharma Investigative Site East Melbourne, Victoria, Australia, 3002 Canada, Ontario Array BioPharma Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Array BioPharma Investigative Site Montreal, Quebec, Canada, H3T 1E2 Germany Array BioPharma Investigative Site Heidelberg, Germany, 69120 Array BioPharma Investigative Site Köln, Germany, 50937 Array BioPharma Investigative Site Muenchen, Germany, 80336 Array BioPharma Investigative Site Würzburg, Germany, 97080 Italy Array BioPharma Investigative Site Napoli, Italy, 80131 Netherlands Array BioPharma Investigative Site Amsterdam, Netherlands, 1066 CX Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Array BioPharma Investigative Site Zuerich, Switzerland, 8091 United Kingdom Array BioPharma Investigative Site Oxford, United Kingdom, OX3 7LJ Collapse << |
| NCT03000374 | Rectal Cancer | Phase 2 | Recruiting | October 2020 | Spain ... more >> Hospital General Universitario de Elche Not yet recruiting Elche, Alicante, Spain, 3203 Contact: Javier Gallego Plazas, MD j.gallegoplazas@gmail.com Hospital de Sabadell Active, not recruiting Sabadell, Barcelona, Spain, 08208 Hospital de Sant Joan Despí Moisés Broggi Active, not recruiting Sant Joan Despí, Barcelona, Spain, 08970 Complejo Hospitalario de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: Ruth Vera Garcia, MD ruth.vera.garcia@cfnavarra.es Hospital de la Santa Creu i Sant Pau Active, not recruiting Barcelona, Spain, 08025 Hospital Universitari Vall d'Hebrón Not yet recruiting Barcelona, Spain, 08035 Contact: Jaume Capdevila, MD jacapdevila@vhebron.net Hospital Clinic i Provincial Active, not recruiting Barcelona, Spain, 08036 Hospital Universitario La Paz Active, not recruiting Madrid, Spain, 28046 Hospital Universitario Virgen del Rocío Not yet recruiting Sevilla, Spain, 41013 Contact: Manuel Valladares, MD mvalaye@icloud.com Fundación Instituto Valenciano de Oncología Active, not recruiting Valencia, Spain, 46009 Consorcio Hospital General Universitario de Valencia Active, not recruiting Valencia, Spain, 46014 Hospital Politécnico Universitario La Fe Not yet recruiting Valencia, Spain, 46026 Contact: Jorge Aparicio Urtasun, MD Contact japariciou@seom.org Collapse << |
| NCT03113604 | - | - | Withdrawn(The study has been s... more >>topped because no one is) Collapse << | - | France ... more >> CHU Amiens Picardie Amiens, Picardie, France, 80054 Collapse << |
| NCT01758575 | - | - | Terminated | - | Netherlands ... more >> VU University Medical Center Amsterdam, Netherlands, 1081HV Collapse << |
| NCT02224781 | BRAF NP_004324.2:p.V600X ... more >> Metastatic Melanoma Recurrent Melanoma Stage III Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Collapse << | Phase 3 | Recruiting | - | - |
| NCT03051035 | Advanced Malignant Neoplasm | Phase 1 | Recruiting | April 15, 2020 | United States, Minnesota ... more >> Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55902 United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Collapse << |
| NCT01281761 | Metastatic Colorectal Cancer | Phase 2 | Completed | - | Korea, Republic of ... more >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Collapse << |
| NCT02416232 | - | - | - | - | France ... more >> GSK Investigational Site Amiens Cedex, France, 80054 GSK Investigational Site Angers, France, 49100 GSK Investigational Site Bayonne cedex, France, 64109 GSK Investigational Site Besancon cedex, France, 25030 GSK Investigational Site Bobigny, France, 93000 GSK Investigational Site Bordeaux, France, 33075 GSK Investigational Site Boulogne-Billancourt, France, 92100 GSK Investigational Site Brest cedex, France, 29609 GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Chambray-Les-Tours, France, 37170 GSK Investigational Site Clermont-Ferrand cedex 1, France, 63003 GSK Investigational Site Creteil, France, 94010 GSK Investigational Site Dijon Cedex, France, 21079 GSK Investigational Site Grenoble cedex 9, France, 38043 GSK Investigational Site La Rochelle cedex 1, France, 17019 GSK Investigational Site Le Havre, France, 76083 GSK Investigational Site Le Mans, France, 72000 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Limoges cedex, France, 87042 GSK Investigational Site Lorient, France, 56322 GSK Investigational Site Lyon Cedex 08, France, 69373 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Montpellier cedex 5, France, 34295 GSK Investigational Site Montpellier Cedex 5, France, 34298 GSK Investigational Site Mulhouse, France, 68100 GSK Investigational Site Nantes Cedex 1, France, 44093 GSK Investigational Site Nice, France, 06202 GSK Investigational Site Nimes, France, 30029 cedex 9 GSK Investigational Site Orleans Cedex 2, France, 45067 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Paris, France, 75006 GSK Investigational Site Pau, France, 64000 GSK Investigational Site Pierre-Benite cedex, France, 69495 GSK Investigational Site Poitiers, France, 86021 GSK Investigational Site Pringy Cedex, France, 74374 GSK Investigational Site Reims Cedex, France, 51092 GSK Investigational Site Rennes Cedex, France, 35042 GSK Investigational Site Rouen, France, 76031 GSK Investigational Site Saint-Pierre, France, 97448 GSK Investigational Site Saint-Priest en Jarez, France, 42270 GSK Investigational Site Strasbourg Cedex, France, 67091 GSK Investigational Site Thionville, France, 57126 Cedex 1 GSK Investigational Site Toulouse Cedex 9, France, 31059 GSK Investigational Site Valence Cedex 9, France, 26953 GSK Investigational Site Vandoeuvre-Les-Nancy, France, 54511 GSK Investigational Site Villejuif cedex, France, 94805 Collapse << |
| NCT03563651 | - | - | Recruiting | February 6, 2020 | United States, California ... more >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Afsaneh Barzi 323-865-3829 Principal Investigator: Afsaneh Barzi Collapse << |
| NCT03223779 | Colorectal Cancer | Phase 1 Phase 2 | Recruiting | January 31, 2025 | United States, Massachusetts ... more >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Theodore S. Hong, MD 617-724-8770 tshong1@mgh.harvard.edu Principal Investigator: Theodore S. Hong, MD Collapse << |
| NCT00551486 | - | - | Completed | - | Korea, Republic of ... more >> Chungnam National University Hospital Daejeon, Korea, Republic of, 301-721 Collapse << |
| NCT02506153 | Metastatic Non-Cutaneous Melan... more >>oma Non-Cutaneous Melanoma Recurrent Melanoma of the Skin Recurrent Non-Cutaneous Melanoma Stage III Cutaneous Melanoma AJCC v7 Stage III Mucosal Melanoma of the Head and Neck AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7 Collapse << | Phase 3 | Active, not recruiting | - | - |
| NCT03049618 | ALK Gene Mutation ... more >> BRAF Gene Mutation EGFR Gene Mutation Head and Neck Squamous Cell Carcinoma Metastatic Head and Neck Carcinoma Recurrent Head and Neck Carcinoma Recurrent Non-Small Cell Lung Carcinoma ROS1 Gene Mutation Stage III Non-Small Cell Lung Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Collapse << | Phase 2 | Recruiting | March 10, 2020 | United States, California ... more >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Jorge J. Nieva 323-865-0421 jorge.nieva@med.usc.edu Principal Investigator: Jorge J. Nieva Collapse << |
| NCT00338377 | Melanoma | Phase 2 | Recruiting | February 2019 | United States, Texas ... more >> The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Patrick Hwu, MD 713-792-2921 phwu@mdanderson.org Principal Investigator: Patrick Hwu, MD Collapse << |
| NCT00897429 | - | - | Recruiting | - | United States, Massachusetts ... more >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Monica Bertagnolli, MD 617-732-8910 Collapse << |
| NCT02399943 | Colorectal Cancer ... more >> KRAS Wildtype NRAS Wildtype BRAF Wildtype Collapse << | Phase 2 | Recruiting | December 2020 | Canada, Ontario ... more >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada Contact: Philippe Bedard, M.D. 416-946-4534 Philippe.Bedard@uhn.ca Collapse << |
| NCT02407509 | Solid Tumours ... more >> Multiple Myeloma Collapse << | Phase 1 | Recruiting | June 2021 | United Kingdom ... more >> Royal Marsden NHS Foundation Trust Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Udai Banerji, MBBS, PhD Guy's and St Thomas' Hospital Not yet recruiting London, United Kingdom Contact: Alison Turner, PhD alison.turner@icr.ac.uk Contact: Joanna Dawes, PhD DDU3808@icr.ac.uk Collapse << |
| NCT03554083 | Clinical Stage III Cutaneous M... more >>elanoma AJCC v8 Pathologic Stage III Cutaneous Melanoma AJCC v8 Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Pathologic Stage IIID Cutaneous Melanoma AJCC v8 Collapse << | Phase 2 | Recruiting | June 29, 2023 | United States, Minnesota ... more >> University of Minnesota/Masonic Cancer Center Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Shernan G. Holtan, M.D. Principal Investigator: Shernan G. Holtan, M.D. Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office 855-776-0015 Principal Investigator: Matthew S. Block, M.D., Ph.D. Collapse << |
| NCT01927419 | - | - | Active, not recruiting | - | - |
| NCT01927419 | Unresectable Melanoma ... more >> Metastatic Melanoma Collapse << | Phase 2 | Active, not recruiting | February 6, 2019 | - |
| NCT01656642 | Malignant Melanoma | Phase 1 | Active, not recruiting | November 28, 2018 | United States, California ... more >> UCLA Los Angeles, California, United States, 90024 The Angeles Clinic and Research Institute - W LA Office Los Angeles, California, United States, 90025 United States, Colorado University of Colorado Health Science Center; Biomedical Research Bldg. Room 511 Aurora, Colorado, United States, 80045 United States, Florida Florida Cancer Specialists - Sarasota Sarasota, Florida, United States, 34232 Florida Cancer Specialists West Palm Beach, Florida, United States, 33401 United States, Massachusetts Massachusetts General Hospital. Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02215 Dana Farber Can Ins Boston, Massachusetts, United States, 02215 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT01521923 | - | - | Completed | - | - |
| NCT03108209 | Phototoxicity | Not Applicable | Recruiting | October 2017 | France ... more >> CHU Nantes Recruiting Nantes, France Contact: Aurélie BOISROBERT Contact 02.40.08.31.22 Collapse << |
| NCT03551626 | Malignant Melanoma | Phase 3 | Recruiting | October 22, 2021 | - |
| NCT01521923 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
| NCT02115035 | Multiple Myeloma | Phase 1 Phase 2 | Withdrawn(Funding issues) | July 2017 | United States, Arkansas ... more >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Collapse << |
| NCT01166126 | Mucosal Melanoma ... more >> Recurrent Melanoma Stage IV Melanoma Collapse << | Phase 2 | Terminated | - | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse << |
| NCT01166126 | - | - | Terminated | - | - |
| NCT01378975 | Malignant Melanoma | Phase 2 | Completed | - | - |
| NCT01723202 | Follicular Thyroid Cancer ... more >> Insular Thyroid Cancer Papillary Thyroid Cancer Recurrent Thyroid Cancer Collapse << | Phase 2 | Active, not recruiting | December 31, 2019 | United States, California ... more >> University of California, San Diego San Diego, California, United States, 92093-0698 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital, Harvard Medical School Boston, Massachusetts, United States, 02114 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Texas The University of Texas-MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT01378975 | - | - | Completed | - | - |
| NCT01519427 | Recurrent Melanoma ... more >> Stage IIIA Melanoma Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Melanoma Collapse << | Phase 2 | Terminated(Study terminated du... more >>e to slow accrual) Collapse << | - | United States, Georgia ... more >> Emory University Atlanta, Georgia, United States, 30322 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Collapse << |
| NCT01519427 | - | - | Terminated(Study terminated du... more >>e to slow accrual) Collapse << | - | - |
| NCT03446157 | Cancer of the Colon ... more >> Colon Cancer Colon Neoplasms Colonic Cancer Neoplasms, Colonic Collapse << | Phase 2 | Recruiting | July 13, 2023 | United States, North Carolina ... more >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599-7295 Contact: Clinical Trials Office - Lineberger Comprehensive Cancer Cente 877-668-0683 Sub-Investigator: Cheryl Carlson, MD Sub-Investigator: Autumn McRee, MD Sub-Investigator: Hanna Sanoff, MD Sub-Investigator: Tammy Triglianos, RN, NP Collapse << |
| NCT01037127 | Cancer | Phase 2 | Completed | - | United States, California ... more >> GSK Investigational Site Los Angeles, California, United States, 90024 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 GSK Investigational Site Nashville, Tennessee, United States, 37232-6307 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030-4009 Australia, New South Wales GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Victoria GSK Investigational Site East Melbourne, Victoria, Australia, 3002 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Collapse << |
| NCT01638676 | Melanoma | Phase 1 Phase 2 | Recruiting | June 2019 | United States, Kentucky ... more >> James Graham Brown Cancer Center-University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Jason A Chesney, MD PhD 502-562-3429 jason.chesney@louisville.edu Contact: Sarah Lush, RN 502-540-1537 s.lush@louisville.edu Collapse << |
| NCT02834364 | Relapsed or Refractory Multipl... more >>e Myeloma Patients With BRAFV600 E or BRAFV600K Mutation Collapse << | Phase 2 | Recruiting | March 2021 | Germany ... more >> Mediz. Klinik und Poliklinik 1, Universitätsklinikum Dresden Not yet recruiting Dresden, Germany, 01307 Contact: Karolin Trautmann-Grill, Dr. Contact: Christoph Roelling, Dr. Universitätsklinikum Frankfurt, Medizinische Klinik II Not yet recruiting Frankfurt/Main, Germany, D-60590 Contact: Ivana von Metzler, Dr. med. ivana.metzler@kgu.de University Hospital Heidelberg, Med. Klinik V Recruiting Heidelberg, Germany, D-69120 Contact: GMMG Study Office studiensekretariat.gmmg@med.uni-heidelberg.de Principal Investigator: Marc Raab, PD. Dr. Universitätsklinikum Köln, Klinik I Innere Medizin Not yet recruiting Köln, Germany, D-50937 Contact: Christof Scheid, Prof. Dr. 0049-221-478-6296 c.scheid@uni-koeln.de Universitätsklinikum Tübingen, Medizinische Klinik II Recruiting Tübingen, Germany, D-72076 Contact: Katja Weisel, Prof. Dr. med. 0049-7071-29-82711 katja.weisel@med.uni-tuebingen.de Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II Recruiting Würzburg, Germany, D-97080 Contact: Mannik Chatterjee, Dr. med. +49 (931) 201-40431 chatterjee_m@ukw.de Collapse << |
| NCT01553851 | Neoplasms, Oral ... more >> Mouth Neoplasms Collapse << | Phase 2 | Completed | - | United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse << |
| NCT00202787 | Colorectal Cancer | Phase 2 | Completed | - | Spain ... more >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD) Madrid, Spain, 28046 Collapse << |
| NCT01553851 | - | - | Completed | - | - |
| NCT00095459 | Neoplasms | Phase 1 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
| NCT02828202 | - | - | Recruiting | March 2021 | France ... more >> CHU d'Amiens Recruiting Amiens, France Contact: Catherine Lok, MD, PhD lok.catherine@chu-amiens.fr Principal Investigator: Catherine Lok, MD, PhD Sub-Investigator: Jean-Philippe Arnault, MD Principal Investigator: Gilles Duverlie, MD, PhD Sub-Investigator: Yves-Edouard Herpe, MD Sub-Investigator: Henri Sevestre, MD, PhD CH Annecy Genevois Recruiting Annecy, France Contact: Julie De Quatrebarbes, MD, PhD jdequatrebarbes@ch-annecygenevois.fr Principal Investigator: Julie De Quatrebarbes, MD, PhD Sub-Investigator: Anne-Claire Bing, MD Sub-Investigator: Benedicte Hars, MD CHU de Besançon Recruiting Besançon, France Contact: François Aubin, MD, PhD francois.aubin@univ-fcomte.fr Principal Investigator: François Aubin, MD, PhD Principal Investigator: Severine Valmary-Degano, MD, PhD Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Avicennes Recruiting Bobigny, France, 93000 Contact: Eve Maubec, MD, PhD eve.maubec@aphp.fr Principal Investigator: Eve Maubec, MD, PhD Sub-Investigator: Gerome Bohelay, MD Sub-Investigator: Valentine Heidelberger, MD Sub-Investigator: Coralie Zumelzu, MD Principal Investigator: Olivier Schischmanoff, MD, PhD Principal Investigator: Antoine Martin, MD, PhD CHU de Bordeaux Hôpital Haut Levêque Active, not recruiting Bordeaux, France CHU de Bordeaux Hôpital Saint-André Recruiting Bordeaux, France Contact: Caroline Dutriaux, MD, PhD caroline.dutriaux@chu-bordeaux.fr Principal Investigator: Caroline Dutriaux, MD, PhD Sub-Investigator: Sorilla Prey, MD Sub-Investigator: H Conte, MD Sub-Investigator: Emilie Gerard, MD Principal Investigator: Jean-Philippe Merlio, MD, PhD Sub-Investigator: Beatrice Vergier, MD, PhD Sub-Investigator: Pierre Dubus, MD Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Ambroise Paré Recruiting Boulogne-Billancourt, France Contact: Philippe Saiag, MD, PhD philippe.saiag@aphp.fr Principal Investigator: Philippe Saiag, MD, PhD Sub-Investigator: Christine Longvert, MD Sub-Investigator: Sophie Lipowicz, MD Sub-Investigator: Amelie Gantzer, MD Sub-Investigator: Daphne Bosset, MD Sub-Investigator: Marie-Florence De Maleissye, MD Sub-Investigator: Adeline Finet, MD Sub-Investigator: Astrid Blom, MD Principal Investigator: Jean-Pierre Rabes, MD, PhD Principal Investigator: Jean-François Emile, MD, PhD CHU de Brest Recruiting Brest, France Contact: Delphine Legoupil, MD delphine.legoupil@chu-brest.fr Principal Investigator: Delphine Legoupil, MD Sub-Investigator: Laurent Misery, MD, PhD Sub-Investigator: Claire Abasq, MD Sub-Investigator: Emilie Brenaut, MD Principal Investigator: Pascale Marcorelles, MD, PhD Sub-Investigator: Marie-Cecile Nicot, MD CHU de Caen Active, not recruiting Caen, France CHU de Dijon Recruiting Dijon, France Contact: Sophie Dalac, MD, PhD sophie.dalac@chu-dijon.fr Principal Investigator: Sophie Dalac, MD, PhD Sub-Investigator: Pierre Vabres, MD Sub-Investigator: Evelyne Collet, MD Sub-Investigator: Geraldine Jeudy, MD Sub-Investigator: Marie-Helene Aubriot Lorton, MD Sub-Investigator: Tony Petrella, MD Sub-Investigator: Bertille Bonniaud, MD Principal Investigator: Alain Bonnin, MD, PhD CHU de Grenoble Recruiting Grenoble, France Contact: Marie-Therese Leccia, MD, PhD mtleccia@chu-grenoble.fr Principal Investigator: Marie-Therese Leccia, MD, PhD Sub-Investigator: Philippe Lorimier, MD Principal Investigator: Nicole Pinel, MD, PhD CHRU de Lille Recruiting Lille, France Contact: Laurent Mortier, MD, PhD laurent.mortier@chru-lille.fr Principal Investigator: Laurent Mortier, MD, PhD Sub-Investigator: Anna Greliak, MD Principal Investigator: Dominique Deplanque, MD, PhD Principal Investigator: Marie-Christine Copin, MD, PhD Centre Léon Bérard Not yet recruiting Lyon, France Contact: Eve-Marie Neidhardt, MD, PhD Principal Investigator: Eve-Marie Neidhardt, MD, PhD Hospices Civils de Lyon Recruiting Lyon, France Contact: Stephane Dalle, PD, PhD stephane.dalle@chu-lyon.fr Principal Investigator: Stephane Dalle, MD, PhD Sub-Investigator: Luc Thomas, MD, PhD Sub-Investigator: Mona Amini-Adle, MD Sub-Investigator: Sebastien Debarbieux, MD Principal Investigator: Alexandra Traverse-Glehen, MD, PhD Sub-Investigator: Nicole Fabien, MD Sub-Investigator: Brigitte Balme, MD Sub-Investigator: Lauriane Depaepe, MD AP-HM Hopital de la Timone Recruiting Marseille, France Contact: Jean-Jacques Grob, MD, PhD jean-jacques.grob@ap-hm.fr Principal Investigator: Jean-Jacques Grob, MD, PhD Sub-Investigator: Caroline Gaudy, MD, PhD Sub-Investigator: Sandrine Monestier, MD Sub-Investigator: Sylvie Hesse, MD Sub-Investigator: Nausicaa Malissen, MD Principal Investigator: Dominique Figarella-Branger, MD, PhD CHU de Montpellier Recruiting Montpellier, France Contact: Bernard Guillot, MD, PhD b-guillot@chu-montpellier.fr Principal Investigator: Bernard Guillot, MD, PhD Sub-Investigator: Aline Montet, MD Sub-Investigator: Anne-Sophie Bertrand, MD Sub-Investigator: Anouck Lamoureux, MD Principal Investigator: Valerie Costes-Martineau, MD, PhD Sub-Investigator: Anne-Marie Dupuy, MD Sub-Investigator: Valerie Rigau, MD CHU de Nancy Recruiting Nancy, France Contact: Florence Granel-Brocard, MD f.granel-brocard@chu-nancy.fr Principal Investigator: Florence Granel-Brocard, MD, PhD Sub-Investigator: Laurent Charbit, MD Principal Investigator: Jean-Michel Vignaud, MD, PhD CHU de Nantes Not yet recruiting Nantes, France Contact: Brigitte Dreno, MD, PhD brigitte.dreno@atlanmed.fr Principal Investigator: Brigitte Dreno, MD, PhD CHU de Nice Recruiting Nice, France Contact: Jean-Philippe Lacour, MD, PhD lacour@unice.fr Principal Investigator: Jean-Philippe Lacour, MD, PhD Principal Investigator: Philippe Bahadoran, MD, PhD Sub-Investigator: Thierry Passeron, MD, PhD Sub-Investigator: Henri Montaudie, MD Sub-Investigator: Florence Le Duff, MD Sub-Investigator: Marine Cavalie, MD Sub-Investigator: Alexandra Picard, MD Sub-Investigator: Feriel Boukari, MD Principal Investigator: Paul Hofman, MD, PhD Sub-Investigator: Veronique Hofman, MD Sub-Investigator: Catherine Butori, MD CHRU de Nîmes Recruiting Nîmes, France Contact: Pierre-Emmanuel Stoebner, MD, PhD pierre.stoebner@chu-nimes.fr Principal Investigator: Pierre-Emmanuel Stoebner, MD, PhD Sub-Investigator: Fanny Fichel, MD Principal Investigator: Thierry Lavabre-Bertrand, MD, PhD Sub-Investigator: Jean-Baptiste Gaillard, MD Sub-Investigator: Pascal Roger, MD, PhD Assistance Publique - Hôpitaux de Paris (AP-HP), Hopital Saint-Louis, centre d'oncodermatologie Recruiting Paris, France Contact: Celeste Lebbe, MD, PhD celeste.lebbe@aphp.fr Principal Investigator: Celeste Lebbe, MD, PhD Sub-Investigator: Jennifer Roux, MD Sub-Investigator: Barouyr Baroudjian, MD Sub-Investigator: Pauline Laly, MD Sub-Investigator: Julie Delyon, MD, PhD Sub-Investigator: Florian Herms, MD Principal Investigator: Dominique Vitoux, MD, PhD Sub-Investigator: Marc Chevrier, MD Sub-Investigator: Mohamad Hinedi, MD Principal Investigator: Anne Janin, MD, PhD Sub-Investigator: Maxime Batistella, MD Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Bichat Recruiting Paris, France Contact: Vincent Descamps, MD, PhD vincent.descamps@aphp.fr Principal Investigator: Vincent Descamps, MD, PhD Sub-Investigator: Beatrice Crickx, MD Sub-Investigator: Charlotte Fite, MD Sub-Investigator: Catherine Picard-Dahan, MD, PhD Sub-Investigator: Valerie Vuong, MD Sub-Investigator: Florence Brunet-Possenti, MD Sub-Investigator: Diane Kottler, MD Principal Investigator: Sarah Tubiana, MD Principal Investigator: Anne Couvelard, MD, PhD Sub-Investigator: Lydia Deschamps, MD Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Cochin Not yet recruiting Paris, France Contact: Marie-Françoise Avril, MD, PhD marie-francoise.avril@aphp.fr Principal Investigator: Marie-Françoise Avril, MD, PhD CHU de Rennes Recruiting Rennes, France Contact: Alain Dupuy, MD, PhD alain.dupuy@chu-rennes.fr Principal Investigator: Alain Dupuy, MD, PhD Sub-Investigator: Marie-Dominique Galibert, MD Sub-Investigator: Monica Dinulescu, MD Sub-Investigator: Cecile Chabbert, MD Sub-Investigator: Catherine Droitcourt, MD Sub-Investigator: Henri Adamski, MD Principal Investigator: Bruno Turlin, MD, PhD CLCC Eugène Marquis Recruiting Rennes, France Contact: Thierry Lesimple, MD, PhD t.lesimple@rennes.unicancer.fr Principal Investigator: Thierry Lesimple, MD, PhD Sub-Investigator: Marc Pracht, MD Principal Investigator: Bruno Turlin, MD, PhD CHU de Toulouse Recruiting Toulouse, France Contact: Nicolas Meyer, MD, PhD meyer.n@chu-toulouse.fr Principal Investigator: Nicolas Meyer, MD, PhD Sub-Investigator: Sophie Thellier, MD Sub-Investigator: Marianne Thomas-Pfaab, MD Sub-Investigator: Cecile Pages Laurent, MD, PhD Principal Investigator: Pierre Brousset, MD, PhD Institut Gustave Roussy Not yet recruiting Villejuif, France Contact: Caroline Robert, MD, PhD caroline.robert@gustaveroussy.fr Principal Investigator: Caroline Robert, MD, PhD Collapse << |
| NCT01683188 | Metastatic Melanoma | Phase 4 | Terminated(A shift in the mela... more >>noma treatment landscape adversely affected accrual & to early closure.) Collapse << | - | - |
| NCT02447939 | Melanoma | Phase 1 | Withdrawn(Change in strategy) | December 2018 | - |
| NCT01363232 | Advanced Solid Tumors ... more >> Selected Solid Tumors Collapse << | Phase 1 | Completed | - | United States, Massachusetts ... more >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02115 United States, Michigan Karmanos Cancer Institute Study Coordinator Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center MSKCC (2) New York, New York, United States, 90033 United States, South Carolina Cancer Centers of the Carolinas CCC Faris Greenville, South Carolina, United States, 29605 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States, 77030-4009 Canada, Ontario Array BioPharma Investigative Site Toronto, Ontario, Canada, M5G 2M9 Germany Array BioPharma Investigative Site Essen, Germany, 45147 Array BioPharma Investigative Site Heidelberg, Germany, 69120 Netherlands Array BioPharma Investigative Site Utrecht, Netherlands, 3584CX Singapore Array BioPharma Investigative Site Singapore, Singapore, 169610 Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Array BioPharma Investigative Site Bellinzona, Switzerland, 6500 Collapse << |
| NCT02065063 | Cancer | Phase 1 | Completed | - | United States, Massachusetts ... more >> GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030-4009 Collapse << |
| NCT01037127 | - | - | Completed | - | - |
| NCT01337765 | Unspecified Adult Solid Tumor,... more >> Protocol Specific Solid Tumor Collapse << | Phase 1 | Completed | - | United States, Massachusetts ... more >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02114 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3050 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Villejuif Cedex, France, 94805 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Collapse << |
| NCT03771404 | Non Small Cell Lung Cancer | Not Applicable | Recruiting | December 1, 2021 | Greece ... more >> 2nd Pneumological Dept, GNA "Sotiria" Recruiting Athens, Attica, Greece, 11527 Contact: Aggeliki Rapti, MD Principal Investigator: Aggeliki Rapti, MD 7th Pneumological Dept, GNA "Sotiria" Recruiting Athens, Attica, Greece, 11527 Contact: Mina Gaga, MD Principal Investigator: Mina Gaga, MD Thoracic Surgery Dept, GNA "Sotiria" Recruiting Athens, Attica, Greece, 11527 Contact: Evaggelos Sepsas, MD Principal Investigator: Evaggelos Sepsas, MD Thoracic Surgery Clinic, "Hygeia" Hospital Not yet recruiting Athens, Attica, Greece, 15123 Contact: Kosmas Iliadis, MD Principal Investigator: Kosmas Iliadis, MD Oncology Unit, 3rd Department of Medicine Athens University School of Medicine Athens, GNA "Sotiria" Recruiting Athens, Greece, 11527 Contact: Konstantinos Syrigos, MD,PhD,FCCP Principal Investigator: Konstantinos Syrigos, MD,PhD,FCCP IASO General Hospital Recruiting Athens, Greece Contact: Vassilis Georgoulias, MD, PhD +302106502639 Principal Investigator: Vassilis Georgoulias, MD, PhD Collapse << |
| NCT03493932 | Glioblastoma | Phase 1 | Recruiting | June 1, 2021 | United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov Collapse << |
| NCT02957266 | Cervical Cancer | Phase 3 | Recruiting | December 2020 | Azerbaijan ... more >> National Center of Oncology Recruiting Baku, Azerbaijan, AZ1011 Contact: Aziz Aliyev, Professor +994504807021 internationalnoc@gmail.com Collapse << |
| NCT02314481 | Non-small Cell Lung Cancer | Phase 2 | Recruiting | January 2023 | United Kingdom ... more >> Univeristy College London Hospital Recruiting London, United Kingdom Contact: Amy Smith Collapse << |
| NCT03405272 | Metastatic Colorectal Cancer | Phase 2 | Not yet recruiting | December 1, 2019 | - |
| NCT03363347 | - | - | Completed | - | - |
| NCT02231775 | BRAF V600E Mutation Present ... more >> BRAF V600K Mutation Present Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Collapse << | Phase 2 | Recruiting | October 31, 2019 | United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Jennifer Wargo 713-745-1553 Principal Investigator: Jennifer Wargo Collapse << |
| NCT02318901 | Advanced Cancer ... more >> Breast Cancer Gastric Cancer Esophageal Cancer Colorectal Cancer Collapse << | Phase 1 Phase 2 | Terminated(PI no longer at sig... more >>ht. Results not collected) Collapse << | - | United States, Arizona ... more >> Western Regional Medical Center/Cancer Treatment Center of America Goodyear, Arizona, United States, 85338 Collapse << |
| NCT02948985 | - | - | Not yet recruiting | December 2019 | - |
| NCT01781026 | - | - | Completed | - | - |
| NCT03429803 | Low-grade Glioma | Phase 1 Phase 2 | Recruiting | December 31, 2024 | United States, Massachusetts ... more >> Massacusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: David H. Ebb, MD 617-726-2737 debb@partners.org Principal Investigator: David H. Ebb, MD Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Karen D Wright, MD 617-632-4309 KarenD_wright@dfci.Harvard.edu Principal Investigator: Karen D Wright, MD Dana-Farber Cancer Institite Recruiting Boston, Massachusetts, United States, 02215 Contact: Karen D. Wright, MD 617-632-4309 KarenD_wright@dfci.Harvard.edu Principal Investigator: Karen D. Wright, MD Collapse << |
| NCT02980510 | Metastatic Colorectal Cancer | Phase 2 | Recruiting | January 2024 | France ... more >> Institut Sainte Catherine Not yet recruiting Avignon, France Contact: Laurent MINEUR l.mineur@isc84.org Principal Investigator: Laurent MINEUR, Dr Centre Léon Berard Not yet recruiting Lyon, France Contact: Christelle DE LA FOUCHARDIERE christelle.delafouchardiere@lyon.unicancer.fr Principal Investigator: Christelle DE LA FOUCHARDIERE, Dr Chu Saint Eloi Not yet recruiting Montpellier, France Contact: Eric ASSENAT e-assenat@chu-montpellier.fr Principal Investigator: Eric ASSENAT, Dr ICM Val D'Aurelle Recruiting Montpellier, France Contact: Thibault MAZARD Thibault.Mazard@icm.unicancer.fr Principal Investigator: Thibault MAZARD, Dr Institut de Cancérologie de Lorraine Not yet recruiting Nancy, France Contact: Céline GAVOILLE c.gavoille@nancy.unicancer.fr Principal Investigator: Céline GAVOILLE, Dr CHU Carémeau - Institut de Cancérologie du Gard Not yet recruiting Nimes, France Contact: Stéphane OBLED stephane.obled@chu-nimes.fr Principal Investigator: Stéphane OBLED, Dr Collapse << |
| NCT03683407 | - | - | Recruiting | August 31, 2019 | China, Shanghai ... more >> Shanghai Changzheng Hospital Recruiting Shanghai, Shanghai, China, 200003 Contact: Xiao-Dong Jiao, MD +86-13817797639 pulava@139.com Principal Investigator: Yuan-Sheng Zang, Professor Collapse << |
| NCT02596113 | - | - | Recruiting | May 2019 | Greece ... more >> Evangelismos Hospital Recruiting Athens, Attiki, Greece, 10676 Contact: Nikos Viazis, Director 00306977617000 nikos.viazis@gmail.com Sub-Investigator: Michalis Galanopoulos, trainee/resident Collapse << |
| NCT01781026 | Melanoma | Phase 2 | Completed | - | United States, Connecticut ... more >> Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States, 06510 Collapse << |
| NCT02392871 | Metastatic Melanoma | Phase 1 Phase 2 | Recruiting | June 2020 | Australia, New South Wales ... more >> St Vincent's Hospital Recruiting Darlinghurst, New South Wales, Australia, 2010 Contact: Ashley Douglas Ashley.Douglas@svha.org.au Principal Investigator: Gerald Fogarty, MBBS Sub-Investigator: Anthony Joshua, MBBS Westmead Hospital Recruiting Sydney, New South Wales, Australia, 2145 Contact: Tracy Pearl-Larsson Tracy.Pearl-Larson@health.nsw.gov.au Principal Investigator: Tim Wang, MBBS Sub-Investigator: Matteo Carlino, MBBS Australia, Queensland Princess Alexandra Hospital Recruiting Brisbane, Queensland, Australia, 4102 Contact: Adrienne See adrienne.see@health.qld.gov.au Principal Investigator: Matthew Foote, MBBS Collapse << |
| NCT02318901 | - | - | Terminated(PI no longer at sig... more >>ht. Results not collected) Collapse << | - | - |
| NCT02910700 | BRAF Gene Mutation ... more >> BRAF wt Allele Stage III Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Collapse << | Phase 2 | Recruiting | December 31, 2021 | United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Hussein A. Tawbi 713-792-2921 Principal Investigator: Hussein A. Tawbi Collapse << |
| NCT01700699 | - | - | Unknown | October 2013 | Italy ... more >> Department of Medicine and Surgery, Univeristy of Salerno Recruiting Baronissi, Salerno, Italy, 84081 Contact: Mario Vitale, MD +39 089672539 mavitale@unisa.it Principal Investigator: Mario Vitale, MD Collapse << |
| NCT02818023 | Melanoma | Phase 1 | Recruiting | October 2019 | United States, Pennsylvania ... more >> UPMC Cancer Center Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Yana M. Najjar, MD 412-623-2294 najjaryg@upmc.edu Contact: Amy Rose, RN, BSN 412-647-8587 kennaj@upmc.edu Collapse << |
| NCT03220035 | Advanced Malignant Solid Neopl... more >>asm Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma BRAF NP_004324.2:p.V600X Ependymoma Ewing Sarcoma Hepatoblastoma Histiocytosis Langerhans Cell Histiocytosis Malignant Germ Cell Tumor Malignant Glioma Osteosarcoma Peripheral Primitive Neuroectodermal Tumor Recurrent Childhood Central Nervous System Neoplasm Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Neuroblastoma Refractory Central Nervous System Neoplasm Refractory Malignant Solid Neoplasm Refractory Neuroblastoma Refractory Non-Hodgkin Lymphoma Rhabdoid Tumor Rhabdomyosarcoma Soft Tissue Sarcoma Wilms Tumor Collapse << | Phase 2 | Recruiting | December 31, 2023 | - |
| NCT01928940 | Solid Tumours | Phase 2 | Completed | - | Japan ... more >> GSK Investigational Site Shizuoka, Japan, 411-8777 GSK Investigational Site Tokyo, Japan, 104-0045 Collapse << |
| NCT03181100 | Malignant Neoplasms of Thyroid... more >> and Other Endocrine Glands Anaplastic Thyroid Carcinoma Poorly Differentiated Thyroid Cancer Collapse << | Phase 2 | Recruiting | July 2023 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations mcabani@mdanderson.org Contact mcabani@mdanderson.org Collapse << |
| NCT01495988 | Melanoma Meta... more >>static Melanoma Collapse << | Phase 2 | Terminated(Slow accrual; toxic... more >>ity; change in priorities) Collapse << | - | United States, California ... more >> The Angeles Clinic Los Angeles, California, United States, 90025 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, District of Columbia Georgetown Lombardi Comprehensive Cancer Center Washington, D.C., District of Columbia, United States, 20007 Washington Cancer Institute at MedStar Washington Hospital Center Washington, D.C., District of Columbia, United States, 20010 United States, Maryland Harry and Jeannette Weinberg Cancer Institute at Franklin Square Baltimore, Maryland, United States, 21237 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York NYU Clinical Cancer Center New York, New York, United States, 10016 Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio OSU Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98109 Collapse << |
| NCT01495988 | - | - | Terminated(Slow accrual; toxic... more >>ity; change in priorities) Collapse << | - | - |
| NCT02175654 | Colorectal Neoplasms ... more >> Metastatic Disease Collapse << | Phase 2 | Terminated(The trial was prema... more >>turely closed due to lack of accrual) Collapse << | - | Spain ... more >> Spanish Cooperative Group for Digestive Tumour Therapy (TTD) Madrid, Spain, 28046 Collapse << |
| NCT01449058 | Advanced and Selected Solid Tu... more >>mors AML High Risk and Very High Risk MDS Collapse << | Phase 1 | Completed | - | United States, California ... more >> University of California San Diego - Moores Cancer Center Dept Onc La Jolla, California, United States, 92093-0658 United States, Florida H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC Tampa, Florida, United States, 33612 United States, Illinois Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital CCPO Boston, Massachusetts, United States, 02114 United States, New York Memorial Sloan Kettering Cancer Center Onc. Dept New York, New York, United States, 90033 Montefiore Medical Center SC The Bronx, New York, United States, 10461 United States, Texas University of Texas/MD Anderson Cancer Center Dept. of Onc. Houston, Texas, United States, 77030-4009 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman (3) Salt Lake City, Utah, United States, 84103 Australia, Victoria Array BioPharma Investigative Site Parkville, Victoria, Australia, 3050 France Array BioPharma Investigative Site Villejuif Cedex, France, 94805 Italy Array BioPharma Investigative Site Milano, MI, Italy, 20133 Array BioPharma Investigative Site Roma, RM, Italy, 00168 Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08036 Switzerland Array BioPharma Investigative Site Bellinzona, Switzerland, 6500 United Kingdom Array BioPharma Investigative Site Sutton, United Kingdom, SM2 5PT Collapse << |
| NCT03015675 | Gastric Cancer | Phase 3 | Recruiting | December 2019 | China, Guangdong ... more >> Medical Oncology,Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Feng Wang, M.D,Ph.D 86-18620880867 wangfeng@sysucc.org.cn Collapse << |
| NCT01240590 | Solid Tumor A... more >>naplastic Thyroid Cancer Collapse << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
| NCT03224767 | BRAF V600E Mutation Present ... more >> Papillary Craniopharyngioma Collapse << | Phase 2 | Recruiting | August 2026 | - |
| NCT00687622 | Solid Tumours | Phase 1 | Completed | - | United States, Arizona ... more >> GSK Investigational Site Scottsdale, Arizona, United States, 85258 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Florida GSK Investigational Site Fort Myers, Florida, United States, 33905 GSK Investigational Site Ocoee, Florida, United States, 34761 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89169 United States, New York GSK Investigational Site Albany, New York, United States, 12206 United States, Ohio GSK Investigational Site Kettering, Ohio, United States, 45409 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77030 United States, Virginia GSK Investigational Site Norfolk, Virginia, United States, 23502 Collapse << |
| NCT01928940 | - | - | Completed | - | - |
| NCT00405587 | Malignant Melanoma ... more >> Colorectal Carcinoma Collapse << | Phase 1 | Completed | - | United States, California ... more >> University of California Los Angeles Los Angeles, California, United States, 90095 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Australia, Victoria Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 Royal Melbourne Hospital Parkville, Victoria, Australia Collapse << |
| NCT02810262 | - | - | Recruiting | June 2019 | France ... more >> Hospices Civils de Lyon - Hôpital Edouard Herriot - Centre des Métastases Osseuses (CEMOS) Recruiting Lyon, France, 69003 Contact: Cyrille Confavreux, MD, PhD +33 4 72 11 74 79 cyrille.confavreux@chu-lyon.fr Contact: Nadège Trehet-Mendel +33 4 72 11 74 46 centre.prevention@wanadoo.fr Collapse << |
| NCT01240590 | - | - | Completed | - | - |
| NCT03206151 | Metastatic Colorectal Cancer | Phase 3 | Recruiting | April 28, 2021 | China, Beijing ... more >> Cancer hospital Chinese academy of medical sciences Not yet recruiting Beijing, Beijing, China, 100021 Contact: yuankai shi, doctor +8613701251865 syuankaipumc@126.com China, Tianjin Tianjing medical university cancer institute and hospital Recruiting Tianjin, Tianjin, China, 300000 Contact: yi ba, doctor +8613752157916 yiba999@163.com Collapse << |
| NCT03415126 | Cancer Malign... more >>ancy Neoplasia Neoplasm Neoplasm Metastasis Colon Cancer Colonic Neoplasms Colon Cancer Liver Metastasis Metastatic Cancer Metastatic Melanoma Metastatic Colon Cancer Metastatic Lung Cancer Non Small Cell Lung Cancer Metastatic Pancreatic Cancer Pancreas Cancer Pancreas Adenocarcinoma Pancreas Neoplasm Metastatic Nonsmall Cell Lung Cancer Metastatic Pancreatic Cancer Collapse << | Phase 1 | Recruiting | May 2020 | United States, Massachusetts ... more >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: Ryan Sullivan, MD United States, Michigan START - Grand Rapids Recruiting Grand Rapids, Michigan, United States, 49546 Principal Investigator: Nehal Lakhani, MD United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Principal Investigator: Filip Janku, M.D. South Texas Accelerated Research Therapeutics Recruiting San Antonio, Texas, United States, 78229 Principal Investigator: Drew Rasco, M.D. NEXT Oncology Recruiting San Antonio, Texas, United States, 78240 Principal Investigator: Anthony Tolcher, M.D Collapse << |
| NCT00959127 | Advanced Solid Tumors ... more >> Advanced or Metastatic Biliary Cancer Metastatic Colorectal Cancer Collapse << | Phase 1 | Completed | - | United States, California ... more >> University of California, Los Angeles Los Angeles, California, United States, 90095 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Maryland The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-1000 United States, Massachusetts Dana-Farber/Harvard Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Ohio Ohio State University Columbus, Ohio, United States, 43221 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Collapse << |
| NCT01640444 | Colorectal Cancer Metastatic | Phase 2 | Active, not recruiting | November 2018 | Spain ... more >> Spanish Cooperative Group for Digestive Tumour Therapy Madrid, Spain, 28046 Collapse << |
| NCT02942706 | Colorectal Cancer | Phase 2 Phase 3 | Not yet recruiting | October 2019 | - |
| NCT02969681 | Colorectal Neoplasms | Phase 3 | Recruiting | December 2020 | China, Guangdong ... more >> Medical Oncology,Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Feng Wang, M.D,Ph.D 86-18620880867 wangfeng@sysucc.org.cn Principal Investigator: Ruihua Xu, M.D,Ph.D Sub-Investigator: Feng Wang, M.D,Ph.D Collapse << |
| NCT02304809 | Solid Tumors ... more >>Hematologic Cancers Metastatic Cancers Collapse << | Phase 2 | Recruiting | February 2022 | France ... more >> Tredaniel Recruiting Paris, France, 75014 Contact: JEAN TREDANIEL, MD 33 1 44 12 78 05 jtredaniel@hpsj.fr Collapse << |
| NCT00405587 | - | - | Completed | - | - |
| NCT03553329 | - | - | Completed | - | France ... more >> CHU DE Poitiers Poitiers, France, 86021 Collapse << |
| NCT01256359 | Melanoma | Phase 2 | Active, not recruiting | December 2018 | United Kingdom ... more >> Churchill Hospital Oxford, Oxfordshire, United Kingdom, OX3 7LJ Collapse << |
| NCT02619058 | Melanoma | Phase 1 | Unknown | October 2017 | China, Beijing ... more >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Chuanliang Cui, MD 0086-10-88196951 1008ccl@163.com Contact: Jun Guo, MD,PHD 0086-10-88196317 guoj307@126.com Principal Investigator: Jun Guo, MD,PHD Collapse << |
| NCT00397982 | Recurrent Melanoma ... more >> Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Collapse << | Phase 2 | Completed | - | United States, Pennsylvania ... more >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Collapse << |
| NCT00397982 | - | - | Completed | - | - |
| NCT01972347 | Melanoma | Phase 2 | Active, not recruiting | May 2022 | Australia, New South Wales ... more >> Melanoma Institute Australia North Sydney, New South Wales, Australia, 2060 Collapse << |
| NCT01336634 | - | - | Active, not recruiting | - | - |
| NCT01794793 | Cushing's Disease ... more >> Acromegaly Neuroendocrine Tumors Pituitary Tumors Ectopic ACTH Secreting (EAS) Tumors Dumping Syndrome Prostate Cancer Melanoma Negative for bRAF Melanoma Negative for nRAS Collapse << | Phase 4 | Recruiting | June 12, 2023 | - |
| NCT02208583 | Hormone Refractory Prostate Ca... more >>ncer Collapse << | Not Applicable | Unknown | December 2016 | China, Tianjin ... more >> Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Wang HaiTao, Ph.D +86-18630955984 peterrock2000@126.com Principal Investigator: Wang HaiTao, Ph.D Collapse << |
| NCT02451553 | Advanced Malignant Solid Neopl... more >>asm Bile Duct Carcinoma Recurrent Malignant Solid Neoplasm Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer AJCC v6 and v7 Stage IVA Pancreatic Cancer Stage IVB Pancreatic Cancer Collapse << | Phase 1 | Recruiting | - | United States, Indiana ... more >> Indiana University/Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Sandra Wilson 317-274-3512 slhooper@iu.edu Principal Investigator: Safi Shahda United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Elena G. Chiorean 206-288-6248 gchiorea@uw.edu Principal Investigator: Elena G. Chiorean Collapse << |
| NCT01208051 | Recurrent Thyroid Gland Carcin... more >>oma Stage I Thyroid Gland Follicular Carcinoma AJCC v7 Stage I Thyroid Gland Papillary Carcinoma AJCC v7 Stage II Thyroid Gland Follicular Carcinoma AJCC v7 Stage II Thyroid Gland Papillary Carcinoma AJCC v7 Stage III Thyroid Gland Follicular Carcinoma AJCC v7 Stage III Thyroid Gland Papillary Carcinoma AJCC v7 Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7 Collapse << | Phase 1 Phase 2 | Active, not recruiting | September 30, 2018 | - |
| NCT01336634 | Cancer | Phase 2 | Active, not recruiting | December 1, 2020 | - |
| NCT01059643 | Ovarian Cancer ... more >> Non Small Cell Lung Cancer Prostate Cancer Colorectal Cancer Gastric Cancer Esophageal Cancer Cancer of Head and Neck Collapse << | Phase 2 | Completed | - | United States, Arkansas ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jonesboro, Arkansas, United States, 72401 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States, 32256 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Macon, Georgia, United States, 31201 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marietta, Georgia, United States, 30060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valdosta, Georgia, United States, 31602 United States, Idaho For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Post Falls, Idaho, United States, 83854 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Westwood, Kansas, United States, 66205 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67214 United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baton Rouge, Louisiana, United States, 70809 United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bethesda, Maryland, United States, 20817 United States, Montana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Billings, Montana, United States, 59102 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Columbus, Ohio, United States, 43219 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oklahoma City, Oklahoma, United States, 73120 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Charleston, South Carolina, United States, 29425 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Germantown, Tennessee, United States, 38138 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Corpus Christi, Texas, United States, 78404 United States, West Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Morgantown, West Virginia, United States, 26506 Collapse << |
| NCT03213691 | Advanced Malignant Solid Neopl... more >>asm Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma BRAF Gene Mutation GNA11 Gene Mutation GNAQ Gene Mutation Histiocytosis HRAS Gene Mutation KRAS Gene Mutation NF1 Gene Mutation NRAS Gene Mutation Recurrent Childhood Central Nervous System Neoplasm Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Neuroblastoma Refractory Central Nervous System Neoplasm Refractory Malignant Solid Neoplasm Refractory Neuroblastoma Refractory Non-Hodgkin Lymphoma Collapse << | Phase 2 | Recruiting | September 30, 2024 | - |
| NCT02465060 | Advanced Malignant Solid Neopl... more >>asm Bladder Carcinoma Breast Carcinoma Cervical Carcinoma Colon Carcinoma Colorectal Carcinoma Endometrial Carcinoma Esophageal Carcinoma Gastric Carcinoma Glioma Head and Neck Carcinoma Kidney Carcinoma Liver and Intrahepatic Bile Duct Carcinoma Lung Carcinoma Lymphoma Malignant Uterine Neoplasm Melanoma Ovarian Carcinoma Pancreatic Carcinoma Plasma Cell Myeloma Prostate Carcinoma Rectal Carcinoma Recurrent Bladder Carcinoma Recurrent Breast Carcinoma Recurrent Cervical Carcinoma Recurrent Colon Carcinoma Recurrent Colorectal Carcinoma Recurrent Esophageal Carcinoma Recurrent Gastric Carcinoma Recurrent Glioma Recurrent Head and Neck Carcinoma Recurrent Liver Carcinoma Recurrent Lung Carcinoma Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Melanoma Recurrent Ovarian Carcinoma Recurrent Pancreatic Carcinoma Recurrent Plasma Cell Myeloma Recurrent Prostate Carcinoma Recurrent Rectal Carcinoma Recurrent Skin Carcinoma Recurrent Thyroid Gland Carcinoma Recurrent Uterine Corpus Carcinoma Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Plasma Cell Myeloma Skin Carcinoma Thyroid Gland Carcinoma Uterine Corpus Cancer Collapse << | Phase 2 | Recruiting | - | - |
| NCT01514864 | Carcinoma, Non-small Cell Lung | Phase 2 | Terminated(Lack of efficacy an... more >>d slow accrual) Collapse << | - | United States, Florida ... more >> H. Lee Moffitt Cancer & Research Institute Tampa, Florida, United States, 33612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Brazil Local Institution Barretos, Sao Paulo, Brazil, 14784 Local Institution S?o Paulo, Sao Paulo, Brazil, 05403 Canada, Ontario The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Germany Local Institution Frankfurt, Germany, 60488 Local Institution Heidelberg, Germany, 69120 Local Institution Heidelberg, Germany, 69126 Local Institution Koeln, Germany, 50924 Local Institution Koeln, Germany, 50931 Poland Local Institution Gdansk, Poland, 80-219 Local Institution Lodz, Poland, 93-509 Local Institution Warsaw, Poland, 02-781 Taiwan Local Institution Taipei, Taiwan, 112 United Kingdom Local Institution Cambridge, Cambridgeshire, United Kingdom, CB2 2QQ Local Institution London, Greater London, United Kingdom, SW3 6JJ Local Institution Manchester, Greater Manchester, United Kingdom, M20 4BX Local Institution Edinburgh, Midlothian, United Kingdom, EH4 2XU Local Institution Sutton, Surrey, United Kingdom, SM2 5PT Local Institution Gwent, United Kingdom, NP20 2UB Collapse << |
| NCT03542877 | Colorectal Cancer | Phase 2 | Recruiting | March 31, 2022 | United States, Arizona ... more >> University of Arizona Recruiting Tucson, Arizona, United States, 85724 Contact: Aaron Scott, MD ajscott@email.arizona.edu Principal Investigator: Aaron Scott, MD United States, Colorado Universtiy of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Amanda Kupniewski 720-848-0643 AMANDA.KUPNIEWSKI@UCDENVER.EDU Principal Investigator: Wells Messersmith, MD Lone Tree Health Center Recruiting Lone Tree, Colorado, United States, 80124 Contact: Wells Messersmith, MD wells.messersmith@ucdenver.edu Principal Investigator: Wells Messersmith, MD United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Usha Malhotra, MD 732-235-8975 um49@cinj.rutgers.edu Principal Investigator: Usha Malhotra, MD United States, Pennsylvania Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Atrayee Basu Mallick, MD Atrayee.BasuMallick@jefferson.edu Principal Investigator: Atrayee Basu Mallick, MD United States, Washington Swedish Medical Center Recruiting Seattle, Washington, United States, 98122 Contact: Philip Gold, MD philip.gold@swedish.org Principal Investigator: Phillip Gold, MD Collapse << |
| NCT01276379 | Colorectal Cancer | Phase 2 | Completed | - | Spain ... more >> Hospital Provincial de Castellón Castelló de la Plana, Castellón, Spain Hospital Son Espases Palma, Malllorca, Spain Hospital Son Llàtzer Palma, Mallorca, Spain Hospital Sant Joan de Reus Reus, Tarragona, Spain Complejo Hospitalario Universitario de Albacete Albacete, Spain Hospital Infanta Cristina de Badajoz Badajoz, Spain Hospital de Barbastro Barbastro, Spain Hospital Clínic de Barcelona Barcelona, Spain Hospital General Yagüe Burgos, Spain Hospital Sant Jaume de Calella Calella, Spain Hospital San Pedro de Alcántara Cáceres, Spain Hospital General Universitario de Elche Elche, Spain Hospital de Jaén Jaén, Spain Hospital Universitario de Gran Canaria Dr. Negrín Las Palmas de Gran Canaria, Spain Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain Fundación Jimenez Díaz Madrid, Spain Hospital de Móstoles Madrid, Spain Hospital Universitario la Paz Madrid, Spain Hospital de Mataró Mataró, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital de Navarra Pamplona, Spain Hospital de Sagunto Sagunto, Spain Mutua de Terrassa Terrassa, Spain Hospital Virgen de la Salud Toledo, Spain Instituto Valenciano de Oncología Valencia, Spain Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain Hospital Miguel Servet Zaragoza, Spain Collapse << |
| NCT01514864 | - | - | Terminated(Lack of efficacy an... more >>d slow accrual) Collapse << | - | - |
| NCT00304525 | Metastatic Melanoma | Phase 2 | Completed | - | United States, Colorado ... more >> University of Colorado Univ.ofColoradoCancerCenter Aurora, Colorado, United States, 80045 United States, Georgia Georgia Regents University Cancer Clinical Research Unit Augusta, Georgia, United States, 30912 United States, Maryland Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Medical Oncology Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Dept of Cancer for Melanoma Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) Boston, Massachusetts, United States, 02215 United States, Pennsylvania University of Pennsylvania Health System Dept of Hospital of UnivofPenn Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Dept of Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Vanderbilt University Medical Center Dept. of Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas University of Texas/MD Anderson Cancer Center Onc. Dept, Houston, Texas, United States, 77030-4009 Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 Collapse << |
| NCT02700763 | Melanoma | Not Applicable | Recruiting | December 2019 | Netherlands ... more >> University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: Geke AP Hospers, MD, PhD +31 50 3612821 g.a.p.hospers@umcg.nl Principal Investigator: Geke A.P. Hospers, MD, PhD Collapse << |
| NCT01059643 | - | - | Completed | - | - |
| NCT01739764 | Neoplasms | Phase 4 | Active, not recruiting | June 24, 2020 | - |
| NCT01858662 | Metastatic Colorectal Cancer | Phase 2 | Terminated(due to poor recrutm... more >>ent) Collapse << | - | Belgium ... more >> Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium, 6000 clinique Saint Luc Bouge, Belgium, 5004 Cliniques universitaires Saint-Luc - UCL Brussels, Belgium, 1200 Centre Hospitalier Jolimont Lobbes La Louvière, Belgium, 7100 CHU liège (Sart Timan) Liège, Belgium, 4000 Clinique Saint Pierre Ottignies Ottignies, Belgium, 1340 CHU-UCL Dinant-Godinne Yvoir, Belgium, 5530 Collapse << |
| NCT01282502 | Adenocarcinoma of the Rectum | Phase 1 | Completed | - | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Collapse << |
| NCT02062697 | Ovarian Epithelial Cancer | Not Applicable | Recruiting | December 2018 | Austria ... more >> Medical University Vienna, Dptm. of Obstetrics & Gynaecology Recruiting Vienna, Austria, 1090 Contact: Paul Speiser, Prof.Dr., MD Belgium University Hospitals Leuven - Department of Obstetrics and Gynaecology Recruiting Leuven, Belgium, 3000 Contact: Ignace Vergote, Prof.Dr.med. +32/1634 ext 4208 ignace.vergote@uzleuven.be Contact: Els Van Nieuwenhuysen, Dr.med. +32 16 34 ext 74 19 joke.deroover@uz.kuleuven.ac.be Czechia Charles University, Pilsen - Medical Faculty Hospital, Department of Obstetrics and Gynecology Recruiting Pilsen, Plzeň Region, Czechia, 301 66 Contact: Jiri Bouda, M.D., Ph.D. boudaj@medima.cz Contact: Alena Bartáková, M.D. alurge@seznam.cz Germany Charité University - Campus Virchow Clinic Recruiting Berlin, Germany, 13353 Contact: Jalid Sehouli, Prof.Dr. Jalid.Sehouli@charite.de Contact: Ioana Braicu, Dr. +49 30 450 564 ext 002 ioana@braicu.de Principal Investigator: Jalid Sehouli, Prof. Dr. med. Klinik Essen Mitte (KEM) Recruiting Essen, Germany, 92 45136 Contact: Anreas Du Bois, Prof.Dr.med. +49 (0) 201 174 ext 34002 a.dubois@kliniken-essen-mitte.de Contact: Florian Heitz, Dr.med. +49 (0) 201 174 ext 34444 f.heitz@kliniken-essen-mitte.de Universitätsklinikum Hamburg-Eppendorf (UKE) Recruiting Hamburg, Germany, 20246 Contact: Sven Mahner, Priv.-Doz. Dr.med. (040) 7410-23800 s.mahner@uke.de Contact: Fabian Trillsch, Dr.med. (040) 7410-23800 f.trillsch@uke.de Collapse << |
| NCT02094872 | Recurrent Melanoma ... more >> Stage IIIA Melanoma Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Melanoma Collapse << | Phase 2 | Active, not recruiting | April 2018 | United States, Arizona ... more >> Mayo Clinic Cancer Center Scottsdale, Arizona, United States, 85259-5499 United States, Connecticut Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States, 06520-8028 United States, Florida Mayo Clinic Cancer Center Jacksonville, Florida, United States, 32224 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0944 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37240 United States, Texas Baylor Sammons Cancer Center Dallas, Texas, United States, 75246 Collapse << |
| NCT01324258 | Solid Tumours | Phase 1 | Completed | - | Japan ... more >> GSK Investigational Site Osaka, Japan, 589-8511 GSK Investigational Site Tokyo, Japan, 181-8611 Collapse << |
| NCT02273336 | - | - | Active, not recruiting | July 22, 2020 | United States, California ... more >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Collapse << |
| NCT02977052 | Malignant Melanoma Stage III | Phase 2 | Recruiting | June 2022 | Australia, New South Wales ... more >> Melanoma Institute Australia Recruiting Sydney, New South Wales, Australia, 2060 Contact: Maria Gonzalez +61299117300 Maria.Gonzalez@melanoma.org.au Principal Investigator: Georgina Long Austria Medical University of Vienna Not yet recruiting Vienna, Austria, 1090 Contact: Christoph Hoeller, Prof. christoph.hoeller@meduniwien.ac.at Principal Investigator: Christoph Hoeller, Prof. Netherlands Netherlands Cancer Institute Recruiting Amsterdam, NH, Netherlands, 1066CX Contact: Christian Blank-de Hoop, Prof. +31205122951 c.blank@nki.nl Contact: Lisette Rozeman, MD +31205126281 l.rozeman@nki.nl Sweden Karolinska Institutet Recruiting Stockholm, Sweden, S-171 76 Contact: Johan Hansson, Prof. Johan.Hansson@ki.se Contact: Leia Ollmar leia.ollmar@sll.se Principal Investigator: Johan Hansson, Prof. Sub-Investigator: Hanna Eriksson, MD PhD Collapse << |
| NCT01262183 | Irresectable Squamous Cell or ... more >>Adenocarcinoma of the Oesophagus Collapse << | Phase 2 | Terminated(low recruitment num... more >>bers) Collapse << | October 2012 | Netherlands ... more >> University Medical Centre Nijmegen Nijmegen, Gelderland, Netherlands, 6500 HB Collapse << |
| NCT01153763 | Melanoma | Phase 2 | Completed | - | United States, California ... more >> GSK Investigational Site Los Angeles, California, United States, 90025 GSK Investigational Site Los Angeles, California, United States, 90095 GSK Investigational Site San Francisco, California, United States, 94115 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030-4009 Australia, New South Wales GSK Investigational Site Newcastle, New South Wales, Australia, 2300 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 France GSK Investigational Site Bordeaux, France, 33075 GSK Investigational Site Boulogne-Billancourt, France, 92100 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Villejuif, France, 94805 Germany GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Luebeck, Schleswig-Holstein, Germany, 23538 GSK Investigational Site Berlin, Germany, 10117 Italy GSK Investigational Site Napoli, Campania, Italy, 80131 GSK Investigational Site Genova, Liguria, Italy, 16132 GSK Investigational Site Padova, Veneto, Italy, 35128 Collapse << |
| NCT01312857 | Metastatic Colorectal Cancer | Phase 2 | Recruiting | March 2019 | United States, New Jersey ... more >> Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Nancy Kemeny, MD 646-888-4180 Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Nancy Kemeny, MD 646-888-4180 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Nancy Kemeny, MD, PhD 646-888-4180 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Nancy Kemeny, MD 646-888-4180 Contact: Michael D'Angelica, MD 212-639-3226 Principal Investigator: Nancy Kemeny, MD Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Nancy Kemeny, MD 646-888-4180 Contact: Michael D'Angelica, MD 212-639-3226 Principal Investigator: Nancy Kemeny, MD Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Nancy Kemeny, MD 646-888-4180 Collapse << |
| NCT03427268 | Advanced Colorectal Cancer | Phase 2 | Active, not recruiting | October 2019 | United States, California ... more >> US017 Los Angeles, California, United States, 90089-9181 Canada, Ontario CA001 Toronto, Ontario, Canada, ON M5G 2M9 Spain ES001 Barcelona, Spain, 08035 ES009 Madrid, Spain, 28041 ES002 Valencia, Spain, 46010 Collapse << |
| NCT01266967 | Melanoma and Brain Metastases | Phase 2 | Completed | - | - |
| NCT02663232 | - | - | Completed | - | - |
| NCT01100840 | - | - | Unknown | - | Singapore ... more >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Ross Andrew Soo, MBBS 65 6772 4624 ross_soo@nuhs.edu.sg Principal Investigator: Ross Andrew Soo, MBBS Collapse << |
| NCT01153763 | - | - | Completed | - | - |
| NCT01266967 | - | - | Completed | - | - |
| NCT02408887 | Low-risk Papillary Thyroid Can... more >>cer Endocrine Malignancy Thyroid Cancer Collapse << | Phase 2 | Active, not recruiting | April 7, 2025 | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
| NCT02380443 | Colorectal Cancer Metastatic | Phase 2 | Unknown | February 2018 | United States, Arizona ... more >> Banner MD Anderson Medical Center Recruiting Gilbert, Arizona, United States, 85234 Collapse << |
| NCT01876511 | MSI Positive Colorectal Cancer... more >> MSI Negative Colorectal Cancer MSI Positive Non-Colorectal Cancers High Tumor Mutation Burden Collapse << | Phase 2 | Recruiting | June 2021 | United States, California ... more >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: George Fisher, MD georgeaf@stanford.edu Principal Investigator: George Fisher, MD United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Susan Sartorius-Mergenthaler, RN 410-614-3644 sartosu@jhmi.edu Principal Investigator: Dung Le, MD Investigator Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, NIH Active, not recruiting Bethesda, Maryland, United States, 20892 United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: John Hays, MD 614-293-6529 John.Hays@osumc.edu Principal Investigator: John Hays, MD United States, Oregon Providence Portland Medical Center Recruiting Portland, Oregon, United States, 97213 Contact: Todd Crocenzi, MD Todd.Crocenzi@providence.org Principal Investigator: Todd Crocenzi, MD United States, Pennsylvania University of Pennsylvania, Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kim R Binder, MD 215-360-0735 Kim.ReissBinder@uphsupenn.edu Principal Investigator: Kim R Binder, MD University of Pittsburgh Cancer Institute Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: James Lee, MD, PhD leejj@upmc.edu Principal Investigator: James Lee, MD; PhD Collapse << |
| NCT02663232 | - | - | Completed | - | Spain ... more >> Oviedo, Asturias, Spain, 33011 Jerez de La Frontera, Cadiz, Spain, 11407 Santander, Cantabria, Spain, 39008 Donostia, Guipuzcoa, Spain, 20080 Palma de Mallorca, Islas Baleares, Spain, 07198 A Coruña, La Coruña, Spain, 15006 Cartagena (Murcia), Murcia, Spain, 30202 Pamplona, Navarra, Spain, 31008 Santa Cruz de Tenerife, Tenerife, Spain, 38010 Bilbao, Vizcaya, Spain, 48013 Barcelona, Spain, 08003 Barcelona, Spain, 08035 Barcelona, Spain, 08036 Barcelona, Spain, 08916 Burgos, Spain, 09006 Caceres, Spain, 10003 Castellon, Spain, 12002 Girona, Spain, 17007 Granada, Spain, 18014 Lerida, Spain, 25198 Madrid, Spain, 28002 Madrid, Spain, 28007 Madrid, Spain, 28034 Madrid, Spain, 28041 Madrid, Spain, 28046 Malaga, Spain, 29010 Murcia, Spain, 30120 Salamanca, Spain, 37007 Sevilla, Spain, 41009 Toledo, Spain, 45004 Valencia, Spain, 41014 Valencia, Spain, 46017 Zaragoza, Spain, 50009 Collapse << |
| NCT00104897 | Melanoma (Skin) | Phase 2 | Completed | - | United Kingdom ... more >> Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Collapse << |
| NCT03751176 | Colorectal Cancer Metastatic | Phase 2 | Recruiting | December 2021 | Spain ... more >> ICO Girona Dr. Josep Trueta Recruiting Gerona, Barcelona, Spain, 17007 Contact: Xavier Hernández, MD xhernandez@iconcologia.net Hospital de Granollers Recruiting Granollers, Barcelona, Spain, 08402 Contact: Rosa Gallego, MD mrgallego@fhag.es Hospital Mutua de Terrassa Recruiting Terrassa, Barcelona, Spain, 08221 Contact: Julén Fernández, MD julenfernandez@mutuaterrassa.cat Hospital General Universitario de Elche Recruiting Alicante, Elche, Spain, 03203 Contact: Javier Gallego, MD j.gallegoplazas@gmail.com Hospital Universitario Fundación Alcorcón Recruiting Alcorcón, Madrid, Spain, 28922 Contact: Juan Carlos Cámara jccamara@fhalcorcon.es H. Universitari Sant Joan de Reus Recruiting Reus, Tarragona, Spain, 43204 Contact: Féliz Muñoz, MD felix.munoz@grupsagessa.com Hospital de La Ribera de Alzira Recruiting Alzira, Valencia, Spain, 46600 Contact: Teresa Taberner, MD mttb2@hotmail.com Hospital Universitario Vall d`Hebron Recruiting Barcelona, Spain, 08035 Contact: Jaume Capdevila, MD jacapdevila@vhebron.net Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Joan Maurel, MD JMAUREL@clinic.cat Hospital de la Santa Creu I Sant Pau Recruiting Barcelona, Spain, 08041 Contact: Anna Virgili, MD avirgili@santpau.cat Hospital Universtiario la Paz Recruiting Madrid, Spain, 28046 Contact: Nuria Rodriguez, MD nuria.rodriguez@salud.madrid.org CIOCC Sanchinarro Recruiting Madrid, Spain, 28050 Contact: Rafaél Álvarez, MD ralvarezgallego@hmhospitales.com Complejo Hospitalario de Navarra Recruiting Navarro, Spain, 31008 Contact: Ruth Vera, MD ruth.vera.garcia@cfnavarra.es Corporació Sanitaria Parc Taulí Recruiting Sabadell, Spain, 08208 Contact: ismael Macías, Md imacias@tauli.cat Fundación Instituto Valenciano de Oncología Not yet recruiting Valencia, Spain, 46009 Contact: Carlos Fernandez-Martos, MD Hospital Universitario Dr. Peset Recruiting Valencia, Spain, 46017 Contact: Carles Bosch, MD bosch_car@gva.es Hospital Universitario y Politécnico La Fe Not yet recruiting Valencia, Spain, 46026 Contact: Jorge Aparicio, MD japariciou@seom.org Collapse << |
| NCT01377025 | Uveal Melanoma | Phase 2 | Unknown | June 2017 | Germany ... more >> Universitätsmedizin Berlin, Charité Campus Benjamin Franklin Berlin, Germany, 12203 Universitätsklinikum Erlangen Erlangen, Germany, 91052 Univesitätsklinikum Essen Essen, Germany, 45147 Collapse << |
| NCT03750175 | - | - | Recruiting | June 1, 2020 | Denmark ... more >> Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Collapse << |
| NCT01366118 | Rectal Cancer | Not Applicable | Completed | - | Spain ... more >> Centro Integral Oncológico Clara Campal Madrid, Spain, 28050 Collapse << |
| NCT01108107 | Colon Cancer | Phase 2 | Completed | - | Denmark ... more >> Department of Oncology, Herlev Hospital Herlev, Denmark, DK-2730 Dept. of Oncology, Hilleroed Hospital Hilleroed, Denmark, 3400 Department of Oncology, Vejle Hospital Vejle, Denmark, DK-7100 Collapse << |
| NCT02331914 | - | - | Recruiting | January 2019 | Netherlands ... more >> Antoni van Leeuwenhoek Hospital Not yet recruiting Amsterdam, Netherlands Contact: N. Steeghs, MD, PhD n.steeghs@nki.nl Principal Investigator: N. Steeghs, MD, PhD University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: A. K. Reyners, MD, PhD +31 50 361 2821 a.k.l.reyners@umcg.nl Principal Investigator: A. K. Reyners, MD, PhD Leiden University Medical Center Not yet recruiting Leiden, Netherlands Contact: A. J. Gelderblom, MD, PhD A.J.Gelderblom@lumc.nl Principal Investigator: A. J. Gelderblom, MD, PhD University Medical Center St. Radboud Not yet recruiting Nijmegen, Netherlands Contact: W. T. van der Graaf, MD, PhD Winette.vanderGraaf@radboudumc.nl Principal Investigator: W. T. van der Graaf, MD, PhD Erasmus MC Not yet recruiting Rotterdam, Netherlands Contact: R. H. Mathijssen, MD, PhD a.mathijssen@erasmusmc.nl Principal Investigator: R. H. Mathijssen, MD, PhD Collapse << |
| NCT03618641 | Melanoma Lymp... more >>h Node Cancer Collapse << | Phase 2 | Recruiting | July 15, 2023 | United States, Pennsylvania ... more >> UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Diwakar Davar, MD 412-623-7368 davard@upmc.edu Contact: Amy Rose, RN 412-647-8587 kennaj@upmc.edu Collapse << |
| NCT00819780 | Colon Cancer ... more >>Colorectal Cancer Rectal Cancer Metastatic Colorectal Cancer Collapse << | Phase 2 | Completed | - | - |
| NCT00338130 | Melanoma | Phase 2 | Completed | - | - |
| NCT00119249 | Stage III Melanoma ... more >> Stage IV Melanoma Collapse << | Phase 2 | Completed | - | United States, New York ... more >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Collapse << |
| NCT00819780 | - | - | Completed | - | - |
| NCT01640405 | Metastatic Colorectal Cancer | Phase 3 | Active, not recruiting | November 2018 | Spain ... more >> Spanish Cooperative Group for Digestive Tumour Therapy Madrid, Spain, 28046 Collapse << |
| NCT03615443 | Non-Small Cell Lung Cancer | Not Applicable | Active, not recruiting | December 31, 2019 | - |
| NCT02188264 | Recurrent Colorectal Carcinoma... more >> Solid Neoplasm Stage IIIA Colorectal Cancer AJCC v7 Stage IIIB Colorectal Cancer AJCC v7 Stage IIIC Colorectal Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Collapse << | Phase 1 | Active, not recruiting | - | United States, California ... more >> University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Colorado University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Missouri Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States, 63141 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse << |
| NCT03136783 | Melanoma (Skin) | Not Applicable | Recruiting | September 22, 2019 | France ... more >> CHU Amiens Picardie Recruiting Amiens, Picardie, France, 80054 Contact: Catherine LOK-CHARLES, PhD +33322455841 lok.catherine@chu-amiens.fr Collapse << |
| NCT02736305 | Ovarian Neoplasms | Phase 2 | Recruiting | June 2019 | Singapore ... more >> National Cancer Centre Singapore Recruiting Singapore, Singapore, 169610 Collapse << |
| NCT02643056 | Advanced Head and Neck Squamou... more >>s Cancer Collapse << | Phase 2 | Completed | - | - |
| NCT01502410 | - | - | Completed | - | - |
| NCT03511963 | Metastatic Colorectal Cancer (... more >>mCRC) Collapse << | Phase 3 | Recruiting | April 30, 2020 | China, Jiangsu ... more >> Nanjing Bayi Hospital Ethics Committee Recruiting Nanjing, Jiangsu, China, 210002 Contact: Linhua Luo 86-025-80864362 luolinhua0513@163.com Principal Investigator: Shukui Qin Collapse << |
| NCT01025453 | Thyroid Cancer | Phase 2 | Completed | - | United States, New Jersey ... more >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Collapse << |
| NCT01025453 | - | - | Completed | - | - |
| NCT01502410 | Childhood Hepatocellular Carci... more >>noma Papillary Thyroid Cancer Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Liver Cancer Recurrent Childhood Rhabdomyosarcoma Recurrent Thyroid Cancer Recurrent Wilms Tumor and Other Childhood Kidney Tumors Collapse << | Phase 2 | Completed | - | - |
| NCT02893085 | - | - | Completed | - | France ... more >> Chu Reims France, Reims, France, 51092 Collapse << |
| NCT03333343 | EGFR-mutant Non-small Cell Lun... more >>g Cancer Collapse << | Phase 1 | Recruiting | May 21, 2021 | Canada, Ontario ... more >> Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Germany Novartis Investigative Site Recruiting Koeln, Germany, 50937 Italy Novartis Investigative Site Recruiting Ancona, AN, Italy, 60126 Novartis Investigative Site Recruiting Milano, MI, Italy, 20162 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Taiwan Novartis Investigative Site Recruiting Tainan, Taiwan, 70421 Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 Collapse << |
| NCT02723240 | Cancer | Phase 1 | Recruiting | June 30, 2019 | United Kingdom ... more >> Belfast City Hospital Not yet recruiting Belfast, United Kingdom, BT9 7AB Principal Investigator: Richard H Wilson, MD Beatson, West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 OYN Principal Investigator: Jeffry Evans, MD, FRCP Oxford University Hospitals NHS Trust Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Sarah P Blagden, Phd, FRCP Collapse << |
| NCT02039947 | Melanoma and Brain Metastases | Phase 2 | Completed | - | - |
| NCT02305615 | - | - | Completed | - | Hungary ... more >> Szent Margit Hospital Budapest, Hungary, 1032 Semmelweis Egyetem Onkologiai Központ Budapest, Hungary, 1083 Szent Imre Hospital Budapest, Hungary, 1115 Orszagos Onkologiai Intezet; B Belgyogyaszati Osztaly Budapest, Hungary, 1122 Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika Budapest, Hungary, 1125 Fövárosi Önkormányzat uzsoki utcai Kórház Budapest, Hungary, 1145 Kenezy Korhaz Rendelointezet Debrecen, Hungary, 4031 Debreceni Egyetem Klinikai Kozpont ; Department of Oncology Debrecen, Hungary, 4032 Petz Aladar Megyei Oktato Korhaz Gyor, Hungary, 9024 Békés Megyei Pándy Kálmán Kórház; Onkologiai tanszek Gyula, Hungary, 5703 Kaposi Mor Teaching Hospital Kaposvár, Hungary, 7400 Bacs-Kiskun Megyei Korhaz, SZTE AOK Oktato Korhaza, Onkoradiologiai Kozpont Kecskemet, Hungary, 6000 Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly Miskolc, Hungary, 3501 Josa Andras Korhaz; Dept of Oncoradiology Nyíregyháza, Hungary, 4400 Pécsi Tudományegyetem Áok; Onkoterapias Intezet Pecs, Hungary, 7624 Szegedi Tudomanyegyetem, AOK, Szent-Gyorgyi Albert Klinikai Kozpont, Onkoterapias Klinika Szeged, Hungary, 6720 Szent Gyorgy Korhaz;Fejer Megyei Szekesfehervar, Hungary, 8000 Tolna Megyei Onkormanyzat Balassa Janos Korhaz Szekszard, Hungary, 7100 Markusovszky Hospital Szombathely, Hungary, 9700 Szent Borbala Korhaz Tatabánya, Hungary, 2800 Veszprem Megyei Csolnoky; Ferenc Korhaz Veszprem, Hungary, 8200 Zala megyei Önkormányzat Kórház és Rendelõintézet Zalaegerszeg, Hungary, 8900 Collapse << |
| NCT01726738 | Stage III Melanoma ... more >> Stage IV Melanoma Unresectable Melanoma BRAF Mutant Melanoma Collapse << | Phase 2 | Completed | - | United States, North Carolina ... more >> Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, North Carolina, United States, 27599 Collapse << |
| NCT02997228 | Colorectal Adenocarcinoma ... more >> Mismatch Repair Deficiency Stage IV Colorectal Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Collapse << | Phase 3 | Recruiting | April 30, 2022 | - |
| NCT03115164 | - | - | Recruiting | August 18, 2017 | France ... more >> CHU Amiens Picardie Recruiting Amiens, Picardie, France, 80054 Contact: Antoine GOURMEL, PhD +33322087648 gourmel.antoine@chhu-amiens.fr Collapse << |
| NCT02142335 | Malignant Melanoma of Skin Sta... more >>ge III Metastatic Melanoma Collapse << | Phase 2 | Unknown | March 2016 | United States, California ... more >> California Cancer Associates For Research,cCARE Recruiting Encinitas, California, United States, 92024 Contact: Edward F McClay, M.D. 760-452-3340 emcclay@pacificoncology.com Contact: Beth c Kimball, RN, OCN 760-452-3909 bkimball@pacificoncology.com Principal Investigator: Edward F. McClay, M.D. Sub-Investigator: Alberto Bessudo, M.D. Collapse << |
| NCT03634982 | Solid Tumors | Phase 1 | Recruiting | October 1, 2021 | United States, California ... more >> UC Irvine Medical Center - Chao Family Comprehensive Cancer Center Recruiting Orange, California, United States, 92868 Contact: Sai-Hong Ignatius Ou, MD, PhD 877-824-3627 ucstudy@uci.edu Principal Investigator: Sai-Hong Ignatius Ou, MD, PhD United States, Florida Sarah Cannon Research Institute - Florida Cancer Specialists Recruiting Sarasota, Florida, United States, 34232 Contact: Terri Peterson 941-377-9993 Principal Investigator: Judy Wang, MD United States, Oklahoma University of Oklahoma - Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Study Coordinator 405-271-8778 ext option 2 Principal Investigator: Susanna Ulahannan, MD United States, Tennessee Sarah Cannon Research Institute - Tennessee Oncology, PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact: ASKSARAH 877-691-7274 ASKSARAH@scresearch.net Principal Investigator: Howard Burris, III, MD Collapse << |
| NCT03174405 | Metastatic Colorectal Cancer | Phase 2 | Active, not recruiting | August 2021 | Germany ... more >> Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany Collapse << |
| NCT00326495 | Metastatic Colorectal Cancer | Phase 2 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
| NCT00326495 | - | - | Completed | - | - |
| NCT01802645 | Colorectal Cancer | Phase 2 | Recruiting | July 2020 | Germany ... more >> Universitätsklinikum der RWTH Aachen Recruiting Aachen, Germany, 52074 Contact: Ulf-Peter Neumann, Prof. Dr. 0241 8085660 chirurgie@ukaachen.de Principal Investigator: Ulf-Peter Neumann, Prof. Dr. Charité Campus Virchow Recruiting Berlin, Germany, 13353 Contact: Daniel Seehofer, PD Dr. med. 030/ 450 652062 daniel.seehofer@charite.de Principal Investigator: Daniel Seehofer, PD Dr. med. Überörtliche Gemeinschaftspraxis Hämatologie/ Onkologie Not yet recruiting Bocholt, Germany, 46397 Contact: Volker Burstedde, Dr. med. 02871/2182669 Dr.burstedde@gmx.de Klinikum Coburg GmbH Not yet recruiting Coburg, Germany, 96450 Contact: Christof Lamberti, PD Dr. med. 09561 / 22-5413 christof.lamberti@klinikum-coburg.de Onkologie Dülmen GbR Not yet recruiting Coesfeld, Germany, 48653 Contact: Manfred Glados, Dr. med. 02541/971893 onko-studien@glados.eu Universitätsklinikum Carl Gustav Carus Recruiting Dresden, Germany, 01307 Contact: Gunnar Folprecht, PD Dr. med. +49 351 458 4794 Gunnar.Folprecht@uniklinikum-dresden.de Contact: Olga Schubert +49 351 7965620 olga.schubert@uniklinikum-dresden.de Principal Investigator: Gunnar Folprecht, PD Dr. med. Klinikum der Johann Wolfgang Goethe Universität Frankfurt am Main Recruiting Frankfurt/ Main, Germany, 60590 Contact: Wolf Otto Bechstein, Prof. Dr. wolf.bechstein@kgu.de Universitätsmedizin Göttingen Recruiting Göttingen, Germany, 37075 Contact: Torsten Liersch, PD Dr. med. 0551/ 398323 tliersch@chirurgie-goettingen.de Principal Investigator: Torsten Liersch, PD Dr. med. Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Dirk Arnold, Prof. Dr. 040/ 7410 55489 d.arnold@uke.de Principal Investigator: Dirk Arnold, Prof. Dr. Klinikum Landshut gGmbH Recruiting Landshut, Germany, 84034 Contact: Florian Loehe, Prof. Dr. 0871 698 3338 florian.loehe@klinikum-landshut.de University hospital Leipzig Recruiting Leipzig, Germany, 04103 Contact: Florian Lordick, Pr. +49 341 97 12560 Florian.Lordick@medizin.uni-leipzig.de Principal Investigator: Florian Lordick, Pr. Johannes-Gutenberg-Universität Recruiting Mainz, Germany, 55131 Contact: Markus Möhler, PD Dr. +49 6131 17 6863 markus.moehler@unimedizin-mainz.de Principal Investigator: Markus Möhler, PD Dr. Klinikum Oldenburg GmbH Recruiting Oldenburg, Germany, 26133 Contact: Claus-Henning Köhne, Prof. Dr. +49 441 403-2610 onkologie@klinikum-oldenburg.de Principal Investigator: Claus-Henning Köhne, Prof. Rems-Murr-Klinikum Winnenden Not yet recruiting Winnenden, Germany, 71364 Contact: Markus Schaich, Prof. Dr. 07195-591 39240 Markus.Schaich@rems-murr-kliniken.de Universitätsklinikum Würzburg Recruiting Würzburg, Germany, 97080 Contact: Volker Kunzmann, PD Dr. med. 0931/20140746 kunzmann_v@medizin.uni-wuerzburg.de Principal Investigator: Volker Kunzmann, PD Dr. med. Collapse << |
| NCT02414750 | Metastatic Melanoma | Phase 2 | Recruiting | December 2018 | Netherlands ... more >> The Netherlands Cancer Institute Recruiting Amsterdam, Netherlands, 1066CX Contact: Bernies Van der Hiel, MD +31205126129 b.vd.hiel@nki.nl Principal Investigator: John B.A.G. Haanen, Prof. VU medical center Recruiting Amsterdam, Netherlands Contact: Fons J.M. Van den Eertwegh, MD PhD +31204444336 vandeneertwegh@vumc.nl Principal Investigator: Fons J.M. Van den Eertwegh, MD PhD Medisch Spectrum Twente Not yet recruiting Enschede, Netherlands Contact: D. Piersma, MD PhD d.piersma@mst.nl Principal Investigator: D. Piersma, MD PhD University Medical Center Groningen Recruiting Groningen, Netherlands Contact: G. A.P. Hospers, Prof. g.a.p.hospers@umcg.nl Principal Investigator: G. A.P. Hospers, Prof. Leiden University Medical Center Recruiting Leiden, Netherlands Contact: H. W. Kapiteijn, MD PhD h.w.kapiteijn@lumc.nl Principal Investigator: H. W. Kapiteijn, MD PhD Maastricht University Medical Center Recruiting Maastricht, Netherlands Contact: M. J.B. Aarts, MD mjb.essers.aarts@mumc.nl Principal Investigator: M. J.B. Aarts, MD University Medical Center St Radboud Recruiting Nijmegen, Netherlands Contact: R. H.T. Koornstra, MD r.koornstra@onco.umcn.nl Principal Investigator: R. H.T. Koornstra, MD Erasmus Medical Center Recruiting Rotterdam, Netherlands Contact: W. H.J. Kruit, MD PhD w.kruit@erasmusmc.nl Principal Investigator: W. H.J. Kruit, MD PhD University Medical Center Utrecht Recruiting Utrecht, Netherlands Contact: F. Y.F.L. de Vos, MD PhD f.devos@umcutrecht.nl Principal Investigator: F. Y.F.L. de Vos, MD PhD Isala Klinieken Recruiting Zwolle, Netherlands Contact: J. W.B. de Groot, MD PhD j.w.b.de.groot@isala.nl Principal Investigator: J. W.B. de Groot, MD PhD Collapse << |
| NCT03374839 | Melanoma | Phase 1 Phase 2 | Recruiting | March 12, 2021 | France ... more >> Nantes University Hospital Recruiting Nantes, France, 44000 Contact: Amir Khammari, PhD amir.khammari@chu-nantes.fr Principal Investigator: Brigitte Dréno, MD, PhD Collapse << |
| NCT03152565 | Colorectal Carcinoma | Phase 1 Phase 2 | Recruiting | May 2020 | Spain ... more >> Hospital Clínic Barcelona Recruiting Barcelona, Spain, 08024 Contact: Joan Maurel Santasusana, M.D. JMAUREL@clinic.cat Principal Investigator: Joan Maurel Santasusana, M.D. Hospital Universitario Vall d'Hebron Not yet recruiting Barcelona, Spain, 08024 Contact: Elena Élez Fernández, M.D. +34 93 274 60 00 ext 6988 meelez@vhio.net Contact: Guillem Argilés +34 93 274 60 00 ext 6988 gargiles@vhio.net Sub-Investigator: Guillem Argilés, M.D. Principal Investigator: Elena Élez Fernández, M.D. Instituto Catalán de Oncológía L'Hospitalet Not yet recruiting Barcelona, Spain Contact: Ramón Salazar Soler, M.D. 93 260 78 22 ramonsalazar@iconcologia.net Principal Investigator: Ramón Salazar Soler, M.D. Hospital Universitario La Paz Not yet recruiting Madrid, Spain Contact: Nuria Rodríguez Salas, M.D. +34 912 071 138 nuria.rodriguez@salud.madrid.org Principal Investigator: Nuria Rodríguez Salas, M.D. Hospital Universitario Puerta de Hierro Not yet recruiting Madrid, Spain Contact: Ana I. Ruiz Casado, M.D. +34 911 91 600 arcasado@salud.madrid.org Contact: Lourdes Gutierrez, M.D. +34 911 91 600 gutinina@gmail.com Principal Investigator: Ana I. Ruiz Casado, M.D. Sub-Investigator: Lourdes Gutierrez, M.D. Hospital Universitario y Politécnico La Fe Not yet recruiting Valencia, Spain, 46009 Contact: Jorge Aparicio Urtasun, M.D. +34 961973139 japariciou@seom.org Contact: David Lorente, M.D. +34 961973139 dlorenteestelles@seom.org Principal Investigator: Jorge Aparicio Urtasun, M.D. Sub-Investigator: David Lorente, M.D. Instituto Valenciano de Oncología Not yet recruiting Valencia, Spain Contact: Carlos Fernández Martos, M.D. +34 96 111 40 42 cfmartos@fivo.org Contact: Ricardo Yaya Tur, M.D. +34 96 111 40 42 ryayatur@gmail.com Principal Investigator: Carlos Fernández Martos, M.D. Sub-Investigator: Ricardo Yaya Tur, M.D. Hospital Universitario Miguel Servet Not yet recruiting Zaragoza, Spain, 50009 Contact: Vicente Alonso Orduña, M.D. +34 976765500 ext 825 valonsoo@salud.aragon.es Contact: Ana Herrero, M.D. +34 976765500 ext 825 herreroa@yahoo.es Principal Investigator: Vicente Alonso Orduña, M.D. Sub-Investigator: Ana Herrero, M.D. Sub-Investigator: Eduardo Polo, M.D. Hospital Clínico Universitario Lozano Blesa Not yet recruiting Zaragoza, Spain Contact: Pilar Escudero Emperador, M.D. +34 976750476 pescudero@salud.aragon.es Contact: Alfonso Yubero Esteban, M.D. +34 976750476 ayubero@salud.aragon.es Principal Investigator: Pilar Escudero Emperador, M.D. Sub-Investigator: Alfonso Yubero Esteban, M.D. Collapse << |
| NCT01721603 | BRAFV600E Melanoma Patients | Phase 2 | Terminated(Low accrual) | - | United States, California ... more >> University of San Francisco, California San Francisco, California, United States, 94115 Collapse << |
| NCT01813214 | - | - | Terminated(Recruitment difficu... more >>lties.) Collapse << | - | - |
| NCT01721603 | - | - | Terminated(Low accrual) | - | - |
| NCT03091257 | Multiple Myeloma | Phase 1 | Recruiting | December 2021 | United States, Massachusetts ... more >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Noopur S. Raje, MD 617-726-3810 Principal Investigator: Noopur S. Raje, MD United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Jeffery Zonder, MD 313-576-8673 zonderj@karmanos.org Principal Investigator: Jeffery Zonder, MD Collapse << |
| NCT00948467 | Advanced Non-hematologic Malig... more >>nancies Advanced Metastatic Melanoma Collapse << | Phase 1 | Completed | - | United States, Michigan ... more >> Wayne State University Karmanos Cancer Institute Detriot, Michigan, United States, 48201 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Collapse << |
| NCT03013491 | Solid Tumor L... more >>ymphoma Collapse << | Phase 1 Phase 2 | Recruiting | December 2021 | - |
| NCT01813214 | Melanoma | Phase 2 | Terminated(Recruitment difficu... more >>lties.) Collapse << | - | United States, District of Col... more >>umbia Georgetown Lombardi Comprehsnive Cancer Center Washington, District of Columbia, United States, 20007 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health System Charlottesville, Virginia, United States, 22903 Collapse << |
| NCT01307397 | - | - | Completed | - | - |
| NCT01307397 | Malignant Melanoma | Phase 3 | Completed | - | - |
| NCT01867697 | Metastatic Colorectal Cancer | Phase 2 | Active, not recruiting | March 2020 | Denmark ... more >> Aalborg University Hospital Aalborg, Denmark, 9100 Aarhus University Hospital Aarhus, Denmark, 8000 Rigshospitalet Copenhagen, Denmark, 2100 Sydvestjysk Hospital Esbjerg, Denmark, 6700 Herlev University Hospital Herlev, Denmark, 2730 Herning Hospital Herning, Denmark Naestved Hospital Naestved, Denmark, 4700 Odense University Hospital Odense, Denmark, 5000 Roskilde Hospital Roskilde, Denmark, 4000 Norway Haukeland University Hospital Bergen, Norway, 5021 Trondheim University Hospital Trondheim, Norway Sweden Akademiska University Hospital Uppsala, Sweden, 751 85 Collapse << |
